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ABSTRACT 
 
A cell with an irreparably damaged genome is genetically programmed to 
undergo cell death, called apoptosis. This is to make sure that such cells are not 
propagating the damaged DNA to their daughter cells, because it will lead to 
accumulation of genetic instability and is thus detrimental to the tissue or the 
organ, and to the organism as a whole. In spite of the highly efficient genetic 
programming to get succumbed to apoptosis, it has been sometimes found that 
some cells can escape from the fate of apoptosis and continue to survive and 
proliferate. Accumulation of such cells forms one of the first steps towards the 
development of cancer. For my dissertation, I have tried to identify the genetic 
mechanisms that aid a cell to survive DNA damage beyond repair. Thus, this 
study will help us understand the genetic routes to predisposition towards 
carcinogenesis and possibly identify new drug targets for cancer therapeutics.  
Using a highly tractable genetic model organism, the fruitfly, Drosophila 
melanogaster, I first modeled irreparable DNA damage in the form of a single 
telomere loss – a mode of DNA damage that cannot be repaired by the DNA 
repair machinery. This served us as a system to assay the fate of cells following 
the DNA damage. In this background, I carried out a genetic screen to identify 
genes that help survival of cells withstanding telomere loss. Here I identified a 
 iv 
singular gene, corp, that inhibits P53-dependent cell death by negatively 
regulating the tumor suppressor, P53. I characterized Corp as the functional 
analog of vertebrate Mdm2 in the Drosophila system. I identified another gene 
through the screen - fs(1)Yb, that reduces cell survival following telomere loss 
possibly by inducing the DDR pathway following telomere loss.  
Overall, my findings indicate that there are distinct genetic pathways that 
negatively or positively regulate cell survival following irreparable DNA damage. 
A tilt towards or away from them causes abnormal proliferation of cells containing 
damaged genome, thus predisposing an organism to cancer development. 
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CHAPTER 1 
 
INTRODUCTION 
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The survival and evolution of life depends on the faithful inheritance of 
information through DNA from mother to daughter cells both in the soma and 
through the germline, with not only accurate DNA replication and distribution of 
genetic material, but also keeping the mutation load in cells to a minimum. The 
beauty of the living system lies in that it has a highly evolved intrinsic surveillance 
system by which it can sense damage to its DNA and respond accordingly, 
thereby maintaining the fidelity of its genome.  
 
Cellular response to DNA damage 
Cellular metabolites, intracellular accumulated ROS, or external 
environmental factors like X-ray, UV irradiation, and toxic mutagenic chemicals 
are constantly inflicting damage to the genome of an organism. Cells are, 
however, well-armed to combat such constant insults. There are primarily three 
branches of this multifaceted damage response pathway that the cells exhibit in 
response to DNA damage: cell cycle arrest, DNA repair, and programmed cell 
death or apoptosis (Jackson and Bartek, 2009).  
A detailed study has been made on the signal transducers following DNA 
damage that triggers the damage response pathways at their downstream. One 
of the classes of signal transducers comprises phospho-inositide kinase (PIK)-
related proteins that include ATM and ATR. Downstream of ATM and ATR are 
two structurally unrelated proteins with overlapping substrate specificity: 
checkpoint serine/threonine kinases CHK2 and CHK1 activate a cascade of 
downstream effector proteins, like p53, BRCA1, Cdc25, Nbs1, etc. that execute 
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the functions of DNA damage responses (Figure 1). Initially, the term checkpoint 
referred to the ‘control mechanism enforcing dependency in the cell cycle’ 
(Hartwell and Weinert, 1989) but later, it was also found to control DNA repair 
and apoptotic induction as well. These pathways are, to a large extent, 
conserved from mammals to lower invertebrates like Drosophila and single-celled 
eukaryotes, such as yeast. Several of the checkpoint genes are essential for 
organismal survival, implying that this pathway has important roles to play in 
functions that are tightly linked to normal cellular physiology. Inactivation of the 
checkpoint pathways leads to cancer development in mammals. 
Cell cycle arrest ensures that the damaged DNA is not replicated and that 
the cells with damaged DNA are not proliferating. In mammals, Chk1 and Chk2 
both play a role in preventing mitotic entry following DNA damage. Evidence 
shows that Chk2 and Chk1 induce inhibitory phosphorylation of Cdc25, which 
then fails to dephosphorylate Cdc2. Arrest at the G2 phase of cell cycle is 
primarily maintained and regulated by phosphorylated Cdc2 (Brown et al., 1999; 
Chaturvedi et al., 1999; Matsuoka et al., 1998; Nurse, 1997; Sanchez et al., 
1997). Further, Chk2-activated p53 induces 14-3-3σ and p21 that play important 
roles in maintaining G2 arrest in response to DNA damage (Bunz et al., 1998; 
Chan et al., 1999). ATR phosphorylates Chk1 at Ser 345 in response to UV light 
both in vivo and in vitro and mice lacking chk1 die in early embryogenesis like 
ATR-/- mice (Kim et al., 1999; Liu et al., 2000; Takai et al., 2000). chk1 mutant 
embryonic stem cells are incapable of preventing mitotic entry after irradiation, 
implying that Chk1 is required for G2/M phase transition checkpoint in response 
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to DNA damage (Liu et al., 2000). Similarly, in Drosophila, ATR/mei-41 induces 
Chk1/grp, which are essential to induce cell cycle arrest in response to DNA 
damage (de Vries, 2005; Song, 2005; Song et al., 2004). grp mutants fail to delay 
anaphase onset following I-CreI-induced double-strand breaks (Royou et al., 
2005). The ATM/tefu and Chk2/mnk pathway also play a role in cell cycle arrest, 
but is not absolutely indispensable (Bi, 2005; de Vries, 2005; Song et al., 2004; 
Xu et al., 2001). 
The wide variety of DNA lesions necessitates multiple DNA repair 
mechanisms (Jackson and Bartek, 2009). For DNA single-strand lesions, the 
mismatched base or region of missing base pairs is recognized and several 
mismatch-repair methods are applied to fix it: (1) Following detection of 
mismatches, the insertion-deletion loop triggers a single-strand incision that is 
worked upon by nuclease, polymerase, and ligase enzymes to repair the damage 
(Jiricny, 2006). (2) Base-excision repair: Here, the DNA glycosylase enzyme 
recognizes the damaged base and mediates its removal (David et al., 2007). (3) 
Nucleotide excision repair: After recognition of the DNA helix-distorting lesions, 
the damage is excised as a 20-30 base-pair long oligonucleotide, thus producing 
a single-stranded DNA, which is then acted upon by DNA polymerase, 
associated factors, and finally ligase for fixing the damage (Hoeijmakers, 2001). 
For DNA double-strand break (DSB) repair, two principle methods are used: (1) 
non-homologous end joining (NHEJ) and (2) homologous recombination (HR). 
NHEJ is error-prone and can occur at any phase of the cell cycle. Here, the DSB 
is recognized by Ku proteins, which then activate DNA protein kinases, leading to 
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recruitment of end-processing enzymes, polymerases and DNA ligase IV to join 
any two double-strand breaks without sequence specificity (Hefferin and 
Tomkinson, 2005; Lieber, 2008). Ku70 and Ku80 deficient mice showed profound 
deficiency in DNA DSB repair and exhibited dwarfism, also indicating their roles 
in growth control (Nussenzweig et al., 1996; Ouyang et al., 1997). HR, which is 
confined to S and G2 phase of cell cycle, is a comparatively faithful mode of 
repair as it uses the sister chromatid to mediate the repair process. ssDNA, 
generated by the Mre11-Rad50-Nbs1 (MRN complex), invades the undamaged 
template strand, is extended by polymerase, and following nuclease, helicase, 
and ligase activity, strand resolution occurs (San Filippo et al., 2008). The DNA 
repair pathway components are highly conserved in Drosophila (Sekelsky et al., 
2000). Loss-of-function mutations of mre11, rad50, and nbs in Drosophila failed 
to repair irradiation-induced DNA damage (Mukherjee et al., 2009). Chk2-
mediated P53 activation induces the transcription of a wide array of DNA repair 
pathway components in single- or double-strand repair, like, Mre11, Rad50, and 
Ku70/Ku80 (Brodsky et al., 2004). Interestingly, a mei-41-mediated, Chk1/Chk2- 
independent DNA repair mechanism through HR has been also reported 
(LaRocque et al., 2007). 
The role of P53 in DNA repair has been widely studied (Sengupta and 
Harris, 2005). Isogenic matched cell lines exposure to a chemical DNA damaging 
agent showed slower base excision repair when they lacked p53 and the repair 
mechanism involves binding to specific transcription factors (Seo et al., 2002; 
Wang et al., 1995). Disruption of the components of the MRN complex also 
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causes failure to repair DNA double-strand breaks (D'Amours and Jackson, 
2002; Tauchi et al., 2002; Williams et al., 2007; Yuan and Chen, 2010).  
Thus, to summarize so far, upon being sensed, DNA damage triggers 
checkpoint mechanisms that arrest cell cycle progression and repair the 
damaged DNA before entering into the next mitotic cycle. However, if the DNA 
damage is beyond repair, the cells may succumb to apoptosis and are thus 
eliminated in order to stem the spread of genetic aberrations and thereby 
maintain genomic stability. 
 
DNA damage beyond repair 
The inability to repair damage usually leads to various types of disorders 
and predisposition towards tumor development. Programmed cell death is a last 
line of defense against the development of cancer. P53 is extremely essential for 
induction of apoptosis following irreparable DNA damage (Fridman and Lowe, 
2003; Vousden and Lu, 2002; Yoshida and Miki, 2010). Humans lacking one 
copy of p53 are predisposed to develop cancers and p53 knockout mice also 
develop cancers at a higher rate (Donehower et al., 1992; Jackson and Bartek, 
2009; Sancar et al., 2004; Zhou and Elledge, 2000). Irradiation-induced chk2-/- 
thymocytes do not have stabilized and activated p53 and have no induction of its 
downstream genes in the apoptotic pathway (Hirao, 2000). In mammals, P53 
positively regulates both intrinsic (mitochrondrially-regulated) and extrinsic (cell-
surface receptor-mediated) apoptotic pathways by transcriptional activation of 
multiple genes and also by transcriptional independent mechanisms (Chipuk and 
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Green, 2006; Haupt, 2003; Yoshida and Miki, 2010). For example, P53 induces 
the pro-apoptotic genes Bax, Noxa, Puma, and Apaf-1 and counteracts the anti-
apoptotic Bad in the intrinsic pathway (Li et al., 2008; Miyashita and Reed, 1995; 
Nakano and Vousden, 2001; Oda et al., 2000; Robles et al., 2001) and the death 
receptors Fas and DR5 (Haupt, 2003) in the extrinsic pathway. P53 also binds to 
the anti-apoptotic BcL-2 and compromises the latter’s ability to stabilize the 
mitochondrial membrane (Wolff et al., 2008), resulting in cytochrome C release – 
that promotes the pro-apoptotic cascade activation.  
Most of the DDR pathways, including cell cycle arrest, DNA repair, and 
apoptosis, are conserved in the Drosophila model. However, in flies, P53 does 
not participate in cell cycle arrest (Sogame et al., 2003); following activation by 
Chk2 in response to DNA damage, it induces DNA repair or apoptosis (Brodsky 
et al., 2004; Kurzhals et al., 2011; Peters et al., 2002; Titen and Golic, 2008). 
Besides, the existence of P53-independent apoptotic pathways have also been 
reported (McNamee and Brodsky, 2009; Titen and Golic, 2008; van Bergeijk et 
al., 2012; Wichmann et al., 2006). 
 
Surviving irreparable DNA damage 
In spite of the multistep checkpoints, a fraction of cells may still continue to 
survive with irreparable DNA damage (Ahmad and Golic, 1999; Kurzhals et al., 
2011; Titen and Golic, 2008). One way by which this can happen is if the DDR 
pathway genes are mutated. There may also be some more defined genetic 
pathways that allow the survival of such cells. It will be very interesting to identify 
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and characterize such pathways, as they will help us elucidate pathways to 
carcinogenesis or other complex human diseases.   
 
Dissertation outline 
In my dissertation, I have made an attempt to understand the genetic 
mechanisms that regulate a cell’s life or death decision in response to irreparable 
DNA damage. In Chapter 2, I will start by describing a genetic method that I have 
used to assay the fate of somatic cells with respect to surviving or succumbing to 
cell death following induction of nonrepairable DNA damage in the form of a 
single telomere loss. In this background of telomere loss, I will present the 
putative genes that I have identified as enhancers and suppressors of cell death, 
using a highly efficient genetic misexpression (EP) screen. In Chapter 3, I will 
describe the characterization of one of the candidate genes from the screen, 
called corp. I will show how Corp functions in a negative feedback loop on the 
tumor suppressor P53 and functions as the functional analog of the vertebrate 
Mdm2. In Chapter 4, I will show my work on the characterization of another 
candidate gene, fs(1)Yb, identified as a inducer of apoptotic phenotype in the 
screen. In Chapter 5, I will address the roles played by p53 and corp on the 
viability of the animals when they are exposed to DNA damaged, caused by 
ionizing radiation. Finally in Chapter 6, I perform a critical analysis of all my 
findings and discuss how they contribute to answering the bigger question 
addressed at the beginning of this dissertation, that is, how a cell survives 
irreparable DNA damage. In the Appendices, I present the entire data sheet of 
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EP screen results and a list of the Drosophila stocks that I have constructed, for 
future reference and use.  
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Figure 1. DNA damage response pathways. Insult to the DNA triggers a 
damage response through signal transducers (like ATM, ATR, and checkpoint 
kinases) and effectors (like p53, Cdc25, nbs1 and BRCA1) that activate multiple 
downstream pathways to combat the damage – cell cycle arrest, DNA repair, and 
apoptosis. Apoptotic response occurs particularly in response to irreparable 
damage. These pathways are mostly conserved from mammals to lower 
invertebrates. 
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Abstract 
The DNA damage response machinery responds to irreparably damaged 
or broken DNA by activating the apoptotic pathway so that such cells are 
eliminated, to help maintain the fidelity of the genome. A chromosome lacking a 
single telomere represents irreparable DNA damage and triggers apoptotic 
response. However, there is evidence that some cells can survive telomere loss 
and continue to proliferate. This is detrimental to the health of the organism as it 
induces genomic instability, genetic imbalance, and predisposes cells towards 
carcinogenesis. So, it is essential to understand the underlying mechanisms by 
which a cell can survive telomere loss. To do that, we first built a tractable 
genetic model of a single telomere loss in somatic cells. We found that some 
cells do survive after a single telomere loss. Then I used this system to carry out 
a genetic misexpression screen to identify genes that behave as inducers or 
suppressors cell death after telomere loss. I identified four suppressors and three 
inducers through this screen.  
 
Introduction 
The normal ends of chromosomes are protected and do not participate in 
chromosomal rearrangements. However, when broken ends are created by 
ionizing radiation, they cannot substitute for normal ends (Muller, 1940). This 
formed the earliest definition of telomere. Telomeres were rediscovered later 
structurally as nucleic acid-protein complexes that protect the end of linear 
chromosomes from end-to-end fusions and solve the end replication problem 
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(Blackburn, 2001). They consist of repetitive sequences at the chromosome 
termini that are bound by proteins, which can recognize the terminal repeats. 
Such a protein is telomerase, which plays a role in extending the repeat 
sequences at the chromosome ends. Most dipterans, however, do not have 
telomerase; instead, the ends are maintained by repeated transposition of 
retrotransposons (Biessmann and Mason, 2003). Despite this difference, the 
telomere capping proteins that protect the chromosome from end-to-end fusion 
events are mostly conserved between the eukaryotes (Cenci et al., 2005) and 
loss of the telomere triggers the similar instability response, suggesting that 
telomere maintenance is an essential phenomenon in a general biological 
perspective. 
A missing telomere poses a unique challenge to the repair machinery. It 
cannot be repaired by methods that reattach two broken ends. In the 1930s, 
while Barbara McClintock was using cytogenetics to follow the fate of broken 
chromosomes in maize, she demonstrated that chromosomes that have lost their 
normal ends undergo end-to-end fusion, forming anaphase bridges that 
subsequently break, and a breakage-fusion-bridge (BFB) cycle follows 
(McClintock, 1939). A single missing telomere is capable of inducing persistent 
genomic instability in the cells. This genomic instability cannot be repaired and 
forms a hallmark of cancer (Al-Mulla et al., 1999; Artandi and DePinho, 2010; 
Murnane, 2010; Ong et al., 1998; Schneider and Kulesz-Martin, 2004). There is 
evidence of aberrant karyotypes including fusion events involving other 
chromosomes, polyploidy, and chromosomal rearrangements in cells that 
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originally had a single telomere loss (Hackett and Greider, 2003; Sabatier et al., 
2005; Sandell, 1993; Titen and Golic, 2008). Such cells usually undergo 
apoptosis to stem the spread of the unstable genome to the daughter cells; 
however, cancer cells exemplify instances where they escape apoptosis and 
continue to survive and proliferate. In Drosophila, a fraction of somatic cells have 
been found to survive after telomere loss (Ahmad and Golic, 1999; Kurzhals et 
al., 2011; Titen and Golic, 2008). It is important to understand how they can 
survive, because that can help us understand the development of cancer.  
Here, I induce irreparable DNA damage in the form of a single telomere 
loss specifically in the developing eye to build a tractable system for 
quantitatively assaying the fate of cells: that is, to find out if they can survive or 
succumb to cell death. We call this the BARTL (Bar + Telomere Loss) assay and 
found that some cells can survive and reconstitute a partial eye after telomere 
loss. In this background, I carried out a genetic misexpression screening to 
identify genes that help cells to survive better or incline them to die faster. My 
screen uncovered four suppressors and three enhancers of the cell death 
phenotype following telomere loss.   
 
Materials and methods 
Drosophila stock collections:  
(1) UAS-FLP stocks used: P{UAS-FLP1.1D}JD1 (BL 4539), P{UAS-
FLP1.1D}JD2 (BL 4540), P{UAS-FLP.Exel}3 (BL 8209) and P{UAS-
FLP}2B and P{UAS-FLP, ry+}SB3 were from our lab stock collection.  
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(2) eyGal4 stocks used: P{Gal4-ey.H}3-8 (BL 5534), P{Gal4-ey.H}4-8 (BL 
5535), P{ey3.5Gal4.Exel}2 (BL 8220), and P{ey3.5Gal4.Exel}3 (BL 8219). 
(3) P{EPgy2}: All available EPgy2 stocks on chromosome X (total # 600) 
were obtained from Bloomington Drosophila Stock Center. For a detailed 
list, refer to Appendix A. 
(3) RNAi stocks used are as follows: 
RNAi-corp: v102751, v16130 
RNAi-CG1632: v106107, v5478 
RNAi-Pdcd4: v16160, v16162, BL 38445 
RNAi-CG8924: v48041, v48042, BL 35705 
RNAi-Med18: v48490, v48491, v28265, v28264, v106760 
RNAi-CG2701: v106635, v25433 
RNAi-fs(1)Yb: BL 35181, BL35301 
RNAi-CG14814: v41553 
RNAi-CrebB17A: v6103 
RNAi-SmG: BL 26617 
RNAi-mthl1: v33136, BL 15318 
(4) Other stocks used: y w/DcY(H1) or simply H1 (Kurzhals et al., 2011), 
[>w+]89A (laboratory stock), P{eyFLP.N}5 (BL5576).  
Crosses:  All crosses were maintained at 25°C on standard cornmeal 
food. 
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Results and discussion 
Irreparable DNA damage is modeled in the form of a single telomere 
loss in the proliferating cells of the eye.  To build a tractable model system 
where the fate of cells following irreparable DNA damage can be observed, we 
induced telomere loss on a single chromosome – a loss that cannot be repaired 
by the DNA repair machinery. The basic blueprint of this method is to induce 
recombination between inverted FRT sites on sister chromatids of the 
chromosome by FLP induction (Golic and Lindquist, 1989), so that a dicentric 
chromosome is produced. When this dicentric chromosome is pulled towards two 
opposite poles during the anaphase of the next mitotic cycle, it will break, 
delivering a chromosome with a broken end/ lost telomere to each of the 
daughter cells.  
For our system, we used flies that carry FRTs on the Y chromosome. This 
chromosome is referred to as the H1 chromosome (Figure 2A), after Heng Xie 
who constructed it. It has inverted FRTs inserted on its long arm, marked by whs. 
Distal to the FRTs is the dominant BS mutation (Fristrom, 1969; Michinomae and 
Kaji, 1973). A y+ gene is located at the tip of its short arm. FLP expression, for 
inducing recombination between the FRT sites, was produced specifically in 
proliferating cells of the eye by the UAS-Gal4 system (Brand and Perrimon, 
1993). On induction of FLP-mediated recombination between the inverted FRTs 
on the H1 chromosome, a dicentric chromosome and a reciprocal acentric 
chromosome are formed and BS is located on the acentric. This acentric 
fragment is frequently lost (Titen and Golic, 2008). Thus, the telomere loss is 
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marked by the loss of BS mutation (Figure 3). Hence this method of inducing 
irreparable DNA damage in the form of a single telomere loss, marked by the 
loss of BS, is called BARTL (BARStone Telomere Loss) (Kurzhals et al., 2011).  
We chose to induce telomere loss specifically in the eye because onset of 
severe apoptosis in the eye due to telomere loss may deplete the eye but should 
not affect the organismal viability, such that even the worst apoptotic phenotype 
can be reliably scored. As we shall see, this assumption is not entirely true, 
primarily because eyeless expression was not completely limited to the eye. We 
chose the Y chromosome for inducing the single telomere loss because it is 
dispensable for the viability of the fly only. Thus, if cells die en masse following 
telomere loss, it can be argued that the effect is solely in response to irreparable 
DNA damage, not due to aneuploidy.  
Somatic cells can survive following irreparable DNA damage.  Now 
that telomere loss is induced, the question is, what fate does this incur to the 
cells: do they all die or do some of them survive? If they all die, we would expect 
to see the ablation of the eye. If some survive in spite of the incurred telomere 
loss, we might see a larger eye owing to survival and proliferation of cells that 
have lost BS.  
I tested different combinations of UAS-FLP and eyelessGal4 (eyGal4) 
transgenic insertion (on chromosome 2 or 3) lines from the Bloomington Stock 
Center in the BARTL assay to check which combination gives the strongest and 
most consistent phenotype. The outcome of each combination is presented in 
Figure 2C-T. The different combinations of UAS-FLP and eyGal4 with H1 gave a 
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variety of eye phenotypes, from no change to a wide range of eye sizes - from no 
eye or tiny eye to wildtype-like eyes, categorized from 1 to 5 (small to large) 
(Figure 2B). As a control, all the UAS-FLP and eyGal4 transgenic lines were 
individually crossed to H1 males to test if they can modify the BS phenotype by 
themselves. They had no effect on BS.  
 For our future experiments, we chose the two best combinations for 
generating telomere loss on H1:  P{UAS-FLP1.D}JD1, P{Gal4-ey.H}4-8 and 
P{UAS-FLP}2B, P{Gal4-ey.H}4-8. When tested for their ability to flip-out a FRT- 
flanked w+ gene, they both produced maximum yellowish orange eye or mosaic 
eye phenotypes (yellowish orange base pigmentation due to the w+ marker of the 
FLP transgene) with a few dark red ommatidia (Table 1). Besides, the P{UAS-
FLP1.D}JD1, P{Gal4-ey.H}4-8 combination mostly produces a consistent 
moderate-sized eye phenotype (Figure 2K), bigger than BS, suggesting that 
some cells do survive following telomere loss and proliferate to reconstitute the 
eye, at least partially. This proved useful because the window of moderate-sized 
eye phenotype could be shifted either to be made worse, to produce tiny eyes as 
an inducer of cell-death phenotype, or to be made better, i.e., wildtype-like eyes 
as a suppressor of cell-death phenotype under different genetic misexpression 
conditions that would modify the cell fate to produce such shifted eye 
phenotypes. I recombined P{UAS-FLP1.D}JD1 and P{Gal4-ey.H}4-8 on 
chromosome 2 over the SM1 balancer chromosome and abbreviated it as the 
eGUF4.8JD1 recombinant. Similarly, I constructed the recombinant for the other 
combination and called it eGUF4.82B. 
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A genetic misexpression screen identifies novel genes that regulate 
somatic cell survival phenotype following irreparable DNA damage.  In 
control y w/H1; eGUF4.82B/+ flies, the BARTL phenotype distribution was 
localized between eye size categories 2 and 3 (Figure 2D). To identify genes that 
regulate DNA damage-induced apoptosis, I carried out a genetic misexpression 
screen using EP elements (Rørth, 1996) in the eGUF4.82B/+-mediated  BARTL 
background and screened for those EP lines that significantly modified this 
BARTL phenotype. For the screen, I crossed y w/H1; eGUF4.82B/SM1, Cy 
males individually to the females of each of the EP stocks in such a way that 
eyGal4 drives telomere loss and EP element-induced misexpression of a random 
endogenous gene in all the proliferating cells of a developing eye (Figure 4). This 
allowed me to assess whether this alteration of gene expression had any effect 
on eye size. I screened ~600 X-chromosome P{EPgy2} lines available at 
Bloomington Drosophila Stock Center. The detailed screening datasheet is 
presented in Appendix I. From this screen, I identified seven elements that 
significantly altered eye size (Figures 5, 6; Table 2) when tested with eGUF4.82B 
and eGUF4.8JD1.  
The identified EP lines’ effects are limited to eyes with telomere loss.  
Next, we wanted to find out if these screened EP lines, induced or uninduced, 
have any modifying effect on BS or wildtype eyes without telomere loss. In order 
to investigate this, I crossed the EP lines with (1) y w/H1; (2) y w/H1 eyGal4- 
4.8/SM1, Cy; (3) y w/Y; eGUF4.8JD1. None of the seven lines have a significant 
modifying effect on BS or wildtype eyes in absence of telomere loss (Table 3). 
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Then, we wanted to determine if the modifying effect of EP on telomere loss 
requires Gal4 (i.e., EP/H1; eyFLP/+). My results show that EP stock # 17674 
produces large eyes after telomere loss without Gal4 dependence (Table 3).  
However, this does not exclude this line from consideration, but it possibly 
indicates that the change in phenotype is due to insertional mutagenesis. In 
support, some of the RNAi lines tested against the candidate gene of this stock, 
MED18, produced large eye phenotype too (Table 4). 
RNAi-mediated knockdown confirms the efficacy of candidate genes 
as a potent modifier of BARTL phenotype.  In order to verify that EP drives the 
BARTL phenotype, I tested RNAi-mediated knockdown of candidate genes for 
reversal of phenotype in the BARTL assay. Of the seven candidates, only 
knockdown of corp (the candidate gene of EP stock #15650) produced a 
phenotype radically opposite to that of EP-mediated overexpression and the 
knockdown of fs(1)Yb (the candidate gene of EP stock #15778) produced a 
somewhat opposite phenotype to that of EP-mediated overexpression (Table 4). 
P{EPgy2} insertion-induced overexpression of corp+ (EP-corp+) modifies the 
BARTL phenotype to produce wildtype eyes following telomere loss, while RNAi-
mediated corp knockdown (RNAi-corp) eliminates the eyes entirely. One 
possibility was that corp might not be the effected gene in the EP line # 15650. 
corp is contained entirely in the intron of a gene, CG1632, which is transcribed in 
the opposite direction and the EP insertion might interfere with CG1632 
expression (Figure 7). However, since the RNAi-mediated knockdown of CG1632 
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did not modify the BARTL phenotype (Table 4), this indicated that corp is likely 
the affected gene in EP line # 15650.  
The fact that RNAi against the rest of the candidate genes failed to 
produce an opposite effect to that of their EP-mediated overexpression, however, 
did not rule out their candidacy as enhancers or suppressors of cell-death 
phenotype following telomere loss. It is possible that the basal level of these 
genes is already quite low in normal conditions and that the knockdown could not 
take the levels down significantly lower beyond their basally low levels to produce 
any observably different phenotype in the BARTL assay. On the other hand, 
overexpression of these genes could increase their levels well above the 
threshold needed to produce a very significant modification of the BARTL 
phenotype. 
An important implication of the uncovering of these candidate genes is 
that when cells survive irreparable DNA damage, it may not be only from 
deleterious mutations in the apoptotic pathway components, but it is also 
possible that there are some defined genetic pathways that control it. 
Characterization of putative genes identified through our screen may shed 
more light into these pathways. Since corp and fs(1)Yb were identified as the two 
most interesting genes in the EP screen as modifiers of cell fate following 
irreparable DNA damage, we chose to further characterize these two genes. 
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Figure 2. BARTL phenotype produced by different combinations of UAS-
FLP and eyGal4. (A) Graphical representation of the DcY(H1) chromosome 
used in the BARTL assay. The DcY(H1) chromosome is a Y chromosome that 
carries y+ on the short arm and BS on the long arm. Inverted FRTs are inserted 
proximal to BS. The centromere is represented as a solid black circle, the 
telomeres as green rectangles, and the BS gene as a red rectangle. The half-
arrows indicate the inverted FRTs. 
(B) The eye phenotype distribution observed in the BARTL assay. The BS 
phenotype of H1 control males is shown at the left. When FLP is expressed 
(ey>FLP), the phenotypes can either remain unchanged (BS) or range from 
headless pharates (category 1) to adults with a fully developed wildtype eye 
(category 5). 
(C-T) The distribution of BARTL eye phenotype produced by males carrying the 
H1 chromosome and different combinations of various UAS-FLP and eyGal4 
stocks tested. N, number of fly eyes scored. 
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Figure 2 continued. 
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Figure 3. The DcY(H1) chromosome and BARTL assay.  
Chromosome breakage and telomere loss in the BARTL assay. The DcY(H1) 
chromosome (drawn as sister chromatids in G2) is a Y chromosome that carries 
y+ on the short arm and BS on the long arm. Inverted FRTs are inserted proximal 
to BS. The centromere is represented as a solid black circle, the telomeres as 
green rectangles, BS gene as a red rectangle, and inverted FRTs as half-arrows. 
When FLP mediates unequal sister chromatid exchange between inverted 
FRTs, a dicentric and an acentric chromosome are produced. In the subsequent 
mitotic anaphase, the dicentric chromosome is pulled to opposite poles and 
usually breaks. Each daughter cell receives a chromosome with a single broken 
end and one or both daughter cells lose the BS-containing acentric fragment.  
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Figure 4. Schematic of the EP screen. The EP screen is designed such that 
telomere loss and an endogenous gene is overexpressed at the same time in the 
developing eye. The eyeless promoter (yellow oval) drives Gal4 (blue rectangle) 
expression specifically in the proliferating cells of the developing eye, where the 
Gal4 protein (blue oval) then binds to the UAS sequence (brown rectangle) 
upstream of FLP gene (red rectangle) and in the EP-element to simultaneously 
overexpress FLP and a random endogenous gene (magenta rectangle) at the 
downstream of the EP insertion. FLP (red oval) induces recombination of the 
FRTs and eventual telomere loss on the H1 chromosome in these cells.  
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Figure 5. EP screen identifies seven lines that suppresses or enhances the 
BARTL phenotype, produced by the y w/H1; eGUF4.8JD1.  
 The distribution of BARTL eye phenotype produced by males of (A) in control 
males following dicentric induction by eGUF4.8JD1; (B) in males carrying 
P{EPgy2}EY03495 (BL 15650); (C) in males carrying P{EPgy2}EY09634 (BL 
16945); (D) in males carrying P{EPgy2}EY00245 (BL 14821); (E) in males 
carrying P{EPgy2}EY10359 (BL 17674); (F)  in males carrying 
P{EPgy2}EY04983 (BL 15778); (G) in males carrying P{EPgy2}EY04780 (BL 
16617); (H) in males carrying P{EPgy2}EY16157 (BL 21192). For the eye 
phenotype distribution, refer to Figure 2B. N, number of fly eyes scored. 
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Figure 6. The seven EP strains identified in the screen suppresses or 
enhances the BARTL phenotype, produced by the y w/H1; eGUF4.82B. The 
distribution of BARTL eye phenotype produced by males of (A) controls following 
dicentric induction by eGUF4.82B; (B) BL 15650; (C) BL 16945; (D) BL 14821; 
(E) BL 17674; (F) BL 15778; (G) BL 16617; (H) BL 21192. For the eye phenotype 
distribution, refer to Figure 2B. N, number of fly eyes scored. 
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Figure 7. EP-element insertion map at corp genomic region. The corp 
genomic region on the X chromosome (blue), corp transcripts (corp-RA), and 
corp cDNA sequence (CDS, color coded magenta); adapted from FlyBase: 
http://flybase.org/reports/FBgn0030028.html). Orange shading denotes the 
protein coding regions and grey shading denotes the 5’ and 3’ UTR regions on 
the corp transcript. The blue arrowhead indicates the site of the EY03495 EPgy2 
insertion, marked by a black empty rectangle. Directionality of EP-mediated 
induction: to the left if arrowhead points up, to the right if arrowhead points down.  
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Table 1. Strength of FLP expression tested by their ability to flip-out w+ 
gene when crossed to P[>w+>].  
 
Stocks tested Eye phenotype of progenies 
P{UAS-FLP2B} 
P(eyGal4}4.8 
70% have orange eyes, 30% 
have mosaic eyes with a few 
w+ (red) ommatidia. 
P{UAS-FLP1.D}JD1 
P(eyGal4}4.8 
100% have yellowish orange 
eyes. 
P(eyGal4}3.8; 
P{UAS-FLP }SB3 
71% have orange eyes, 29% 
have mosaic eyes with a few 
w+ (red) ommatidia. 
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Table 2. EPgy2 lines identified as modifiers of BARTL phenotype induced 
by y w/H1; eGUF4.8JD1/+.  
 
P{EPgy2} 
stocksa 
Target 
gene 
Cytogenetic 
map 
Nb BARTL 
phenotypec 
Functional 
annotationd 
15650 corp 7E1-7E1 256 100% cat. 5 p53-dependent, 
irradiation-
induced, 
apoptosis-related 
16945 Pdcd4 12B4-12B10 244 98% cat. 4, 
2% BS 
stem cell 
differentiation 
14821 CG8924 14A1-14A1 178 99% cat. 4, 
1% cat. 2 
transcriptional 
regulation during 
cell proliferation 
17674 Med18 2B13-2B13 197 100% cat. 5 RNA pol II 
transcriptional 
mediator 
15778 fs(1)Yb 3B3-3B3 38 100% cat. 1 germline stem cell 
maintenance 
16617 CrebB-17A 17A7-17A8 36 98% cat. 1, 
2% cat. 4 
cAMP-regulated 
transcription 
21192 SmG/mthl1 14F4-14F4 40 100% cat. 1 mitotic spindle 
organization 
 
a P{EPgy2} stocks numbers mentioned are according to the Bloomington 
Drosophila Stock numbers.  
b Numbers of flies scored. 
c BARTL phenotypes are categorized according to that depicted in Figure 2B. 
d Functional annotations are adapted from the information in FlyBase summary of 
individual genes. 
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Table 3. Control results for EPgy2 lines on BS or wildtype eyes.  
 
P{EPgy2} 
  stocksa 
Eye phenotypes for genotypes testedb 
y w /H1 y w/H1; 
eyGal4-4.8 
y w/Y; 
eGUF4.8JD1/SM1, 
Cy 
y w/H1; 
{eyFLP.N}5/SM1, Cy 
15650 100% BS 100% BS 100% cat. 5 1% BS, 1% cat. 2, 47% 
cat. 3, 45% cat. 4, 6% 
cat. 5 
16945 100% BS 100% BS 100% cat. 5 5% BS, 24% cat. 2, 
71% cat. 3 
14821 100% BS 100% BS 100% cat. 5 5% BS, 24% cat. 2, 
71% cat. 3 
17674 100% BS 100% BS 100% cat. 5 22% cat. 4, 78% cat. 5 
15778 100% BS 98% BS, 
2% cat. 5 
100% cat. 5 4% BS, 17% cat. 2, 
50% cat. 3, 29% cat. 4 
16617 98% BS, 2% 
cat. 5 
90% BS, 
10% cat. 2 
100% cat. 5 63% cat. 3, 37% cat. 5 
21192 - 100% BS - - 
 
a P{EPgy2} stocks numbers mentioned are according to the Bloomington 
Drosophila Stock numbers.  
b Eye phenotypes are categorized within the range BARTL eye phenotype, 
depicted in Figure 2B. 
 
 
 
 
 
 
 
 
 44 
Table 4. Effect of candidate gene knockdowns or amorphic alleles on 
BARTL phenotype.   
 
Candidate 
genes in EP 
stocks 
RNAi 
linesa 
Nb BARTL eye phenotype (%)c 
BS 1 2 3 4 5 
corp v102751 32 0 100 0 0 0 0 
v16130 48 0 88 12 0 0 0 
CG1632 v106107 184 4 0 23 73 0 0 
v5478 42 5 0  24 71 0 0 
Pdcd4 v16160 49 0 0 0 100 0 0 
v16162 114 4 0 23 73 0 0 
BL 38445 38 13 0 42 42 3 0 
CG8924 v48041 96 4 0 28 68 0 0 
v48042 98 7 0 21 72 0 0 
BL 35705 32 0 0 25 53 11 11 
MED18 v48490 126 0 0 18 29 52 1 
v48491 18 0 0 0 0 61 39 
v28265 28 7 0 29 25 39 0 
v28264 24 0 0 0 100 0 0 
v106760 30 10 0 13 77 0 0 
CG2701 v106635 192 11 0 20 12 57 0 
v25433 162 0 0 14 62 23 1 
fs(1)Yb BL 35181 52 15 0 12 29 19 25 
 BL 35301 38 5 0 21 39 11 24 
CG14814 v41553 8 0 50 12 38 0 0 
CrebB-17A v6103 38 0 0 100 0 0 0 
mthl1 v33136 46 4 0 39 57 0 0 
BL 15318 116 2 0 0 33 59 6 
SmG BL 26617 60 50 0 27 23 0 0 
 
a RNAi lines are obtained from Bloomington Stock Center (BL) and Vienna 
Drosophila Resource Center (v). 
b Numbers of flies scored. 
c The range of BARTL phenotype is categorized according to that depicted in 
Figure 2B.  
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CHAPTER 3 
 
IDENTIFICATION OF CORP AS A FUNCTIONAL ANALOG OF MDM2: 
NEGATIVE REGULATION OF P53 IN DRSOPHILA MELANOGASTER 
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Abstract  
We identified the corp gene of Drosophila melanogaster as a negative 
regulator of P53. Its overexpression promotes survival of cells with DNA damage 
in the soma but eliminates such cells in the germline, similar to the effects of a 
p53 null mutation in these tissues. Corp is also a transcriptional target of P53, 
thus constituting a negative feedback loop. We find that Corp shares conserved 
protein motifs with Mdm2, the major negative regulator of P53 in vertebrates, and 
physically interacts with Drosophila P53. Our findings show that Drosophila Corp 
is a functional analog of vertebrate Mdm2. 
 
Introduction 
Cells frequently encounter damage to their DNA as the result of intrinsic 
insults, such as replication stress, oxidative stress, and telomere shortening, or 
from exposure to environmental stressors such as mutagenic chemicals or 
radiation. In response to DNA double-strand breaks (DSBs), DNA damage 
response (DDR) pathways are triggered. The ensuing signaling cascades result 
in cell cycle arrest, induction of DNA repair genes, and in some cases, apoptosis. 
It is generally thought that if damage cannot be repaired, cells will undergo 
apoptosis rather than continue to divide and propagate a damaged genome. If 
cells with irreparable damage do survive and proliferate, it can result in 
widespread genomic instability, creating an early state in the progress towards 
cancer 1-3. In Drosophila melanogaster, most cells undergo apoptosis in response 
to irreparable DNA damage, but a few cells escape, continue to divide and 
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exhibit genomic instability 4-6. In our current study, we aimed to investigate the 
genetic mechanisms that allow cells to survive in the presence of irreparably 
damaged DNA.  
One of the key players that controls the fate of a cell following DNA 
damage is the tumor-suppressor encoded by the p53 gene, which has been 
found to be mutated in most forms of human cancers 7. In response to DNA 
damage, the ATM kinase (encoded by tefu in Drosophila) phosphorylates Chk2 
(encoded by lok), which in turn phosphorylates and activates P53 8-10. ATM may 
also phosphorylate P53 directly 11-14. Activated P53 is primarily a transcriptional 
regulator that promotes or inhibits the expression of a large number of target 
genes 15-21. These genes encode a variety of cellular functions such as DNA 
repair, cell cycle arrest, and apoptosis. A cell that detects damage and engages 
the P53 damage response pathway may either repair the damage or experience 
senescence or death 22. Humans that lack one copy of p53 are prone to develop 
cancers, and p53 knockout mice develop cancers at an increased rate 1-3,23,24. 
Similarly, p53-null Drosophila fail to eliminate cells with a DSB in their genome 
5,24,25-27.  
The Mdm2 gene is a prominent target of P53 in mammals. It encodes a 
ubiquitin ligase that negatively regulates P53 and promotes its degradation, 
constituting a negative feedback loop 28,29. Mediation of apoptosis by P53 is 
highly conserved throughout metazoa, including Drosophila melanogaster 21,22,25-
27,30. However, apart from DNA repair genes, targets of p53 that antagonize 
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apoptosis have yet to be reported in flies and no homolog of Mdm2 has been 
identified. 
Here, we report the identification of a gene, companion of reaper (corp), 
whose overexpression mimics the effects of p53 mutants in the soma and the 
germline. Our experiments indicate that Corp is a negative regulator of P53. 
Furthermore, corp has been previously identified as a positively-regulated 
transcriptional target of P53 18,19,31. We also identified protein motif similarity 
between Corp and Mdm2, and found that Corp physically interacts with 
Drosophila P53. Although BLAST searches have failed to identify an Mdm2 
homolog in Drosophila, our results indicate that corp encodes a functional 
equivalent. These findings further strengthen the functional conservation of the 
P53 pathways between Drosophila and mammals. 
 
Results  
Corp suppresses tissue ablation resulting from DNA damage.  The 
previously described BARTL (Bar and Telomere Loss) assay 24 was used to 
screen for insertions of a P-element misexpression element 32 that modify the 
eye phenotype resulting from the production of an irreparable DNA DSB. In brief, 
a combination of eyeless-Gal4 (eyGal4) and UAS-FLP is used to drive FLP 
recombinase expression in proliferating cells of the eye throughout development 
33-35. These flies also carry a Y chromosome with inverted FRT repeats (DcY(H1), 
or simply H1). Recombination between FRTs in inverted orientation on sister 
chromatids produces dicentric chromosomes which break in the subsequent 
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mitotic division, delivering a chromosome with a single broken end to each of the 
two daughter cells (Figure 3). This results in substantial P53-mediated apoptosis 
and produces flies with characteristic small and rough eyes (Figure 8B). By 
introducing an EP transposon insertion, which carries UAS elements that can 
drive expression of a neighboring gene, the flies’ eyes may become larger or 
smaller, indicating that the EP element in question modifies the fate of cells in 
these eyes. We identified one such EP insertion (P{EPgy2}CG1632EY03495) that 
produced nearly wildtype eyes in the BARTL assay (Figure 8C). This insertion 
was ideally placed to drive expression of the corp+ gene (CG10965). By qRT-
PCR we confirmed that when Gal4 induces the P{EPgy2}CG1632EY03495 element 
(hereafter referred to as EP-corp+), it drives overexpression of corp+ (Figure 9). 
We also constructed a UAS-corp+ transgene, and found that its effect was nearly 
identical to that produced by EP-corp+ (Figure 8D).  
When we tested RNAi-mediated knockdown of corp in the BARTL assay, 
the opposite result was obtained: the eye was completely ablated (Figure 8E; n. 
b., ey expression extends beyond the eye proper, accounting for, in some cases, 
nearly complete ablation of the head). A corp mutant was also generated by 
imprecise excision of a P element located in the 5’ region of the gene. This 
mutant, corp95B (Figure 10), is viable in homozygous condition and without 
obvious phenotype on its own. However, like RNAi-mediated corp knockdown, 
corp95B completely ablates the eye in the BARTL assay (Figure 8F). This effect 
can be rescued by the UAS-corp+ transgene (Figure 8G).  
If EP-corp+ was not induced by Gal4, and eyFLP was instead used to 
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produce dicentric chromosomes in the eye, we found that the EP-corp+ insertion, 
by itself, had no effect (Figure 11B). This further confirms that corp+ 
overexpression is necessary to generate the large eye phenotype in the BARTL 
assay.  
To determine whether corp has any influence in the absence of DNA, 
damage we examined wildtype or BS flies carrying EP-corp+, induced or 
uninduced, and flies carrying the corp95B mutant, but without the induction of 
dicentric chromosomes. There was no change in eye phenotype in any of these 
cases, indicating that the effects of altered corp+ expression are seen only after 
DNA damage (Figure 11C-G).  
EP-corp+-mediated rescue of the eye is not confined to males, or to effects 
produced by the Y chromosome. We generated XXY females carrying eyGal4, 
UAS-FLP and the DcY(H1) chromosome and found that EP-corp+ produced 
almost wildtype eyes, similar to its effect in males (Figure 11H-I). Additionally, we 
found that corp+ overexpression ameliorated the reduction in eye size produced 
by dicentric induction on chromosome 3 (Figure 11J-K). Therefore, the effect of 
corp+ overexpression is independent of the sex of the fly or the particular 
chromosome experiencing damage. 
Extant corp polymorphisms are functionally indistinguishable.  We 
sequenced the corp genomic regions from five laboratory strains and found two 
allelic variants of corp that differed by 7 nucleotide changes. Four nucleotide 
changes were found in the second exon: two of them are silent mutations (C840T 
and C891T) and two (T725A and T873G) encode different amino acids (L96H 
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and L145M). These alternate amino acids are also present as polymorphisms in 
wildtype isolates of D. melanogaster and other Drosophila species 
(http://www.dpgp.org). There were also three single nucleotide differences 
(C277T, A398C, and A407T) in introns. 
The UAS-corp+ transgene that we constructed and tested (as mentioned 
previously) carries the canonical version, as found in CantonS. The EP-corp+, y w, 
and w1118 strains all carry the variant allele that differs from the reference 
CantonS strain. Because the overexpression of either allele produces a similar 
large eye phenotype in the BARTL assay (Figure 2D), we conclude that both 
alleles function similarly, and that the two amino acid differences have, at most, 
minor effects.  
corp+ overexpression inhibits DNA damage-induced apoptosis in the 
soma.  Overexpression of corp+ might produce larger eyes in the BARTL assay 
by blocking the apoptotic response, thereby allowing survival and proliferation of 
cells that would normally die. To test this, we examined wing imaginal discs for 
apoptotic cells in wildtype and EP-corp+ larvae following exposure to ionizing 
radiation (IR). We induced corp+ overexpression in the posterior compartment of 
wing discs using an engrailed-Gal4 driver 36 and marked this compartment by co-
induction of UAS-GFP. Apoptosis was significantly reduced by corp+ 
overexpression (Figure 12A, C). We then found that IR-induced apoptosis was 
significantly enhanced in wing discs from corp95B mutants relative to wildtype 
(Figure 12B, D). The results show that corp+ is a potent negative regulator of 
apoptosis. 
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Overexpression of corp+ restricts the transmission of healed 
chromosomes through the germline.  In the male germline, broken dicentric 
chromosomes may be healed by de novo telomere addition 37,38. With DcY(H1), 
these healed chromosomes (denoted FrY) may be detected in testcrosses to y w 
females by the loss of the dominant BS marker that lies distal to the inverted 
FRTs (i.e., by the generation of Bar+ sons). To assess the effect of corp on the 
transmission of broken-and-healed chromosomes, we induced expression of FLP 
by heat shock (70FLP10) during the first 24 hours of development and used 
nanosGal4 to drive germ cell-specific overexpression of corp+. Overexpression of 
corp+ blocked transmission of FrY chromosomes (Table 5). 
We also drove corp+ and FLP expression specifically in the germline using 
nanosGal4 (EP-corp+; UAS-FLP nanosGal4) and again observed a large 
decrease in FrY transmission relative to males with unaltered corp expression 
(Table 5), confirming that corp+ inhibits transmission of broken-and-healed 
chromosomes through the male germline.  
The relationship between corp and p53.  Though it seems surprising 
that corp+ overexpression produces dissimilar phenotypes in the soma (survival 
and proliferation of cells with broken chromosomes) vs. the germline (elimination 
of cells with broken chromosomes), there is precedent: the p535A-1-4 loss of 
function mutation acts similarly. The p535A-1-4 homozygotes have almost wildtype 
eyes in the BARTL assay 24, but strongly reduced transmission of broken-and-
healed chromosomes through the male germline 39. This similarity suggests a 
functional relationship between corp and p53.  
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To explore this relationship, we generated corp95B; p535A-1-4 double 
mutants and examined them using the BARTL assay. We found that p53 is 
epistatic to corp, with the double mutant producing almost wildtype eyes (Figure 
13A). In a complementary experiment, we tested the effect of simultaneously 
overexpressing corp+ and p53+. When GMR-Gal4 drives p53+ overexpression in 
the developing eye, the adults that eclose have very small eyes, owing to an 
elevated frequency of cell death. We found that if corp+ was simultaneously 
overexpressed, the eyes became significantly larger. Furthermore, when we 
combined the corp95B mutant with GMR>p53+, the eyes were much smaller than 
produced by GMR>p53+ alone (Figure 13B). The mutant and overexpression 
results may both be accommodated under the hypothesis that Corp antagonizes 
P53, either by suppressing its apoptotic effects or by negatively regulating P53 
itself. 
P53 level is elevated in corp mutant or knockdown cells.  To 
determine how Corp might affect P53, we examined P53 levels in eye discs by 
immunostaining. The GMR promoter was used to overexpress p53+ behind the 
morphogenetic furrow, providing an easily detected level of expression. The 
corp95B mutant eye discs exhibited a significantly higher level of P53 while EP- 
corp+ overexpression driven by GMR-Gal4 reduced the level of P53 (Figure 14A, 
B). To verify these results, we knocked down corp in S2 cells by treating with 
double-stranded RNA (dsRNA) against corp and measured P53 protein levels by 
Western blot. We found that the quantity of P53 was significantly elevated 
following corp knockdown (Figure 14C, D). Thus, we conclude that Corp is a 
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negative regulator of p53. Since it has been previously shown that corp is a 
transcriptional target of P53, our data indicate that Corp acts in a negative 
feedback loop on p53+. 
We used qRTPCR to measure p53 transcript levels in corp mutant flies, or 
flies with corp+ overexpression, to determine whether corp regulates the level of 
p53 mRNA. We find that there are no significant or consistent changes in p53 
mRNA levels between these genotypes (Figure 15). We conclude that Corp 
regulation of P53 occurs primarily at the level of translation or protein stability.  
Overexpression of corp+ suppresses Hid- and Reaper- mediated cell 
death.  P53 is well known as a positive regulator of the hid and reaper pro-
apoptotic genes. Recently it was shown that these genes act recursively to 
increase p53 expression and contribute to the apoptotic program 40. Given that 
Corp overexpression results in downregulation of P53, we expect that it should 
also suppress the apoptotic phenotype caused by hid and reaper overexpression 
by attenuating this feedback loop. In order to test this prediction, we 
overexpressed hid or reaper in the eye under control of the GMR-Gal4 driver. 
This produced adults with small eyes owing to cell death in the eye discs. When 
corp+ was overexpressed at the same time, the eyes became significantly larger, 
confirming that Corp interferes with the hid- and reaper-mediated apoptotic 
programs (Figure 13C).  
Corp shares protein motif similarity with the P53-interacting regions 
of Mdm2.  Mdm2 is the major negative regulator of P53 in vertebrates. However, 
no homolog of Mdm2 has been found in Drosophila. Given that Corp acts in a 
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negative feedback loop on P53, we looked more closely at Corp to see whether 
any similarities to Mdm2 might be identified. We used the domain analysis tool 
MEME 41,42 to search for shared motifs. When the software was presented with 
four Mdm2 orthologs (H. sapiens, M. musculus, G. gallus, and D. rerio) and Corp 
from two Drosophila species (D. melanogaster and D. virilis) and was instructed 
that each protein sequence may or may not contain similar motifs, it identified 
seven similar motifs, with motifs 4 and 5 shared by Mdm2 and Corp (Figure 16A). 
Interestingly, motif 4 appears to correspond to the N-terminal region of Mdm2 
that interacts with the transactivation domain of P53 and motif 5 appears to 
correspond to the central P53-binding site on Mdm2 44,45.  
Corp physically interacts with P53.  Motivated by the finding of 
similarities between Corp and Mdm2 in regions of Mdm2 that bind P53, we asked 
whether Drosophila Corp and P53 physically interacted in cells. To probe 
whether Corp can directly interact with Drosophila P53 (DmP53), we purified 
GST-DmP53 using a bacterial expression system.  C-terminal-tagged Corp-
GFPFlag was then expressed via transient transfection of HeLa or 293 cells. Cell 
lysates extracted from these cells were incubated with either GST or GST-
DmP53.  Corp-GFPFlag was pulled-down specifically by GST-DmP53 but not by 
GST (Figure 17A), indicating that Corp expressed in mammalian cells interacts 
with DmP53. This result suggests either that Corp can interact directly with 
DmP53, or that the complex required for their interaction is conserved in 
mammalian cells. To further probe this, we tested the interaction between GST-
DmP53 and in vitro synthesized Corp.  We found that, similar to what we 
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observed with cellular lysates, GST-DmP53 strongly interacts with in vitro 
synthesized Corp (Figure 17B).  Together, these results strongly suggest that 
Corp can interact directly with DmP53.  
 
Discussion  
Several studies have identified transcriptional targets of P53 in Drosophila. 
Some of these play important roles in DNA damage repair or in triggering 
apoptosis 18-21,46,47. However, the functions of most P53 target genes have yet to 
be determined. Our discovery that corp+ antagonizes apoptosis by negatively 
regulating P53 is the first demonstration in Drosophila that a P53-regulated gene 
(apart from DNA repair genes) is not solely devoted to apoptosis, and shows that 
P53 target genes act in competing pathways: the hid- and reaper-mediated pro-
apoptotic pathway, and the corp-mediated anti-apoptotic pathway (Figure 16B). 
By increasing or decreasing the expression of corp+, the balance is shifted in 
favor of survival or death, respectively.  
In vertebrates, the major negative regulator of P53 is Mdm2. It binds to 
P53 and ubiquitinates it, leading to its degradation, and is responsible for 
restraining P53 activity in unstressed cells. Furthermore, Mdm2 is also a 
transcriptional target of P53, and is utilized to turn down the P53 response so 
that cells that have recovered from the initiating stress, for instance DNA damage, 
may survive. Though no strict Mdm2 homolog is known in Drosophila, our 
experiments indicate that Corp provides that function. Similar to Mdm2, the corp 
gene is a transcriptional target of P53, Corp antagonizes the P53-mediated 
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apoptotic program, P53 levels are inversely correlated with corp+ expression, and 
Corp physically interacts with P53. Additionally, Corp shares protein motifs with 
vertebrate Mdm2 and these correspond to regions of Mdm2 that physically 
interact with P53. These similarities lead us to propose that Corp is the functional 
analog of mammalian Mdm2.  
There are, nonetheless, significant differences between Corp and Mdm2. 
Mdm2 is an E3 ubiquitin ligase containing a RING domain 48. Corp shows no 
evidence of such a domain. But, recent work 49 established that subunits of the 
proteasome are the predominant physical interactors of Corp (Figure 18). We 
suggest that Corp, like Mdm2, promotes degradation of P53. In contrast to Mdm2, 
Corp may achieve this by recruiting P53 to the proteasome, rather than by 
ubiquitination.  
In the mouse, many Mdm2 mutations cause recessive lethality, though 
they can be rescued by the additional mutation of p53 50, indicating that lethality 
results from unrestrained P53 activity. In contrast, the corp95B null mutation is not 
lethal and exhibits no obvious phenotype in the unstressed condition. Corp 
appears to function only when DNA damage is detected. The normal level of P53 
expression is insufficient to cause lethality in the absence of Corp, unless P53 is 
activated by upstream kinases.  
However, these differences between Corp and Mdm2 may not be as 
significant as they appear. First, recent findings in mice indicate that the 
constitutive and induced levels of Mdm2 can be functionally separated. When the 
P53 Response Element was mutated in the promoter of Mdm2, so that Mdm2 
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was still expressed at a basal level but could no longer be induced to high levels 
by P53, the resulting mice were viable 51. Furthermore, when the RING domain of 
Mdm2 was mutated, so that it no longer functioned as a ubiquitin ligase, but 
could still interact with its partner Mdmx, the mice were also viable 52. In both 
cases, the mice were still highly sensitive to induced DNA damage, indicating 
that higher levels of Mdm2 activity are required to recover from DNA damage. 
Moreover, the latter experiments show that Mdm2 is capable of repressing P53 
function without its ubiquitin ligase activity 52. This may indicate that P53-Mdm2 
binding is a more ancient mode of regulation, with the ubiquitin ligase activity 
acquired as a later adaptation in vertebrates. 
There is still room for alternative or additional explanations for Corp’s 
phenotypes. If Corp targeted downstream components of the apoptotic pathway 
for degradation, it might also lead to the phenotypes we observed. Given the 
existence of a positive feedback loop between downstream pro-apoptotic genes 
and p53 40, Corp might indirectly affect P53 levels by promoting degradation of 
components of the pro-apoptotic pathway. However, detection of a physical 
interaction between Corp and P53 strongly suggests that Corp directly regulates 
P53, regardless of whether it may also regulate downstream apoptotic 
components. 
Corp is the first reported negative regulator of P53 in Drosophila that is 
also a transcriptional target of P53. Although Bonus and Rad6 have been 
identified as negative regulators of P53 in Drosophila 53,54, neither of them are 
transcriptional targets of P53, and are thus less similar to Mdm2 than is Corp. 
 61 
Recent experimental findings from others 19,30,40,55, and as reported here, indicate 
that regulation of P53 is complex, involving activation by upstream factors, with 
both positive and negative feedback loops affecting its activity. Further 
investigation of how these pathways are regulated and how they affect these 
outcomes should greatly improve our understanding of the many functions of P53.  
It remains to be understood what benefit might be provided by Corp. If it is 
normally beneficial to eliminate a cell with unrepaired DNA damage, preventing 
its proliferation, then what purpose could be served by saving such cells from 
death? Previous experiments have shown that in wildtype larvae, many cells with 
damaged genomes are not eliminated by apoptosis immediately, but rather over 
a period of a few days 5. Since corp mutants show increased cell death after 
irradiation, Corp is clearly one factor that restrains the immediate death of cells 
with damaged genomes. We have often thought it surprising that flies can survive 
when dicentric chromosomes are formed, and break, in >90% of their cells during 
development 5,6. Perhaps if all cells with broken chromosomes immediately 
succumbed to apoptosis, such flies would not survive. In fact, corp mutants 
survive very poorly after widespread induction of Y chromosome dicentrics. Corp, 
then, may be advantageous to modulate the rate at which cells are eliminated 
following DNA damage. If >90% of cells in a developing imaginal disc were 
eliminated at the same time, it is easy to imagine that the few remaining survivors, 
adrift in a sea of dead cells, might not be capable of regenerating a complete disc. 
If, instead, the cells with damaged genomes could be eliminated gradually, it 
might give the surviving cells a suitable matrix to regenerate an entire disc. This 
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could be the vital function fulfilled by Corp. Bilak et al., (2014) 56 recently showed 
that dying cells signal their neighbors to become resistant to damage-induced 
death. We would not be surprised to find that this pathway acts through Corp. 
 
Material and methods 
Drosophila stocks.  All flies were maintained at 25°C on standard 
cornmeal food. Construction of the DcY(H1) and Dc3(FrTr61A5)1A 
chromosomes have been described previously by Kurzhals et al. (2011) 24 and 
p535-A-1-4 by Xie et al. (2004) 57. We obtained the following stocks from the 
Bloomington, IN (USA) Drosophila Stock Center: P{UAS-FLP1.D}JD1 (BL 4539), 
P{Gal4-ey.H}4-8 (BL 5535), P{EPgy2}CG1632EY03495 (BL 15650), P{eyFLP.N}5 
(BL5576), M{3xP3-RFP.attP}ZH-86Fb; M{vas-int.B}ZH-102D (BL 23648), P{UAS-
2xeGFP}AH2 (BL 6874), nanos-Gal4 58, P{GMR-p53.Ex}3/TM3, Sb, Ser (BL 
8417), GMR-Gal4 59, P{GMR-hid}G1/CyO (BL 5771), P{GMR-rpr.H}S/TM6B, Tb 
(BL 5773), and P{Act5C-Gal4}17F01/TM6B, Tb (BL 3954). Two corp-RNAi 
stocks were obtained from VDRC: v102751 and v16130. The following stocks 
were obtained from Golic lab collections: heat-shock inducible FLP, P{70FLP}10, 
P{UAS-GFP} P{Act-Gal4}/CyO, and y w; Sp/CyO; nanosGal4 UAS-FLP(95%). 
The engrailed-Gal4 stock was kindly gifted by Mark Metzstein.  
Plasmids and transgenic constructions.  The coding region of corp 
from CantonS flies was amplified by PCR with 5’ NotI and 3’ XbaI overhangs 
(primers used: Fwd-5’CATATTCGCGGCCGCATGGCCGATATCAGGAGCAG3’ 
and Rev- 5’CCGCGGGTCTAGACTAGATGCGAATCGAGCGCA3’) and cloned 
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into the pUAST-w+-attB transgenic fly vector 60. Vector plasmid was injected in 
embryos carrying attP docking sites on chromosome 3 and vasa-ΦC31 integrase 
on chromosome 4 (BL 23648). w+ flies were selected for establishing stable 
transgenic stocks. 
The corp95B deletion mutation was generated via imprecise excision of the 
EY03495 P-element insertion (Baylor College of Medicine Genome Disruption 
Project).  The DNA break points were identified by PCR amplification (primer sets 
used: Fwd 1: 5’CCAAGCGAACGCATCGCTG3’, Fwd 2: 
5’GAAGAGGTCATCTCCCAAGG3’, Rev1: 5’CTTAGGAACAATGGTTCAACC3’, 
and Rev2: 5’GCAGCCGAGGTATGGAAATC3’ and sequencing of genomic DNA 
obtained from the homozygous mutant. 
DNA sequencing.  Sequencing of corp+ from the genomic region in five 
different genotypes, y w, w1118, EP-corp+, CantonS, and v; Sco/Cy; ry, was carried 
out by the Core Facilities, University of Utah.  
Eye photographs.  Eye photographs were taken using a Nikon D200 
digital camera and processed in Adobe Photoshop. 
Quantitative reverse transcriptase PCR.  Total RNA was extracted from 
12-15 adults or third instar larvae using Trizol Reagent (Sigma Aldrich, MO), 
treated with DNaseI (Fermentas, PA), and cDNA was synthesized using 
RevertAidTM First Strand cDNA synthesis kit (Thermo Scientific, PA) according to 
manufacturer’s protocol. 1µl of cDNA was used per reaction in triplicates for 
performing qRT-PCR experiment using MaximaTM SYBR green/Fluorescein 
qPCR Master Mix (Fermentas, PA) or PerfeCTa SYBR Green FastMix (Quanta 
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Biosciences, MD) in an iQ-PCR machine (Bio-Rad, CA). Relative quantification of 
mRNA levels was calculated using the standard curve method. Relative copy 
numbers of each gene of interest (X) was calculated by normalizing cDNA levels 
of X over cDNA levels of Ribosomal Protein L32. Primers that were used are: 
Fwd-corp: 5’ GCAGCCGAGGTATGGAAATC 3’; Rev-corp: 
5’AAGCCGAGGGTCAGAAGG 3’; Fwd-p53: 5’ GCCGCCTCCTTAATCATGCC 
3’; Rev-p53: 5’ GCCGAGACTGCGACGACTC 3’;  
Fwd-rpl: 5’ CCGCTTCAAGGGACAGTATC3’; Fwd-rpl: 5’ 
ATCTCGCCGCAGTAAACG 3’. 
Irradiation.  15-18 wandering third instar larvae were collected in clean 10 
mm petri plates and irradiated at 4000 rads in a TORREX120D X-ray generator 
(Astrophysics Research Corp, CA), set at 110kV and 5mA. These larvae were 
returned to fresh food and incubated at 25°C until further experimental 
treatments. 
Eye size measurement.  For determining eye sizes, the left eye of each 
fly was measured along the anterio-posterior axis (A) and the dorso-ventral axis 
(B), using a digital filar micrometer (Lasico, CA). Then these two measurements 
were used to calculate the area of an ellipse (i.e., Π x A/2 x B/2), as the area of 
the eye. Then this area was normalized over mean of the area of wildtype (w1118 
or y w) eyes and was represented as a fraction of wildtype eye size.  
Germline fragment chromosome transmission assay.  Flies were 
allowed to lay eggs and transferred to fresh vials every day. Embryos were 
collected for 24 hrs, heat-shocked at 38°C for 1 hour in a circulating water bath 
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and then immediately returned to 25°C. After eclosion, the males were collected 
and singly mated to 2-3 y w females and their progeny were scored. Alternatively, 
nosGal4 was used to drive UASFLP in the male germline.  
Imaginal disc staining procedures and fluorescence microscopy. 
Wing and eye imaginal discs were dissected from third instar larvae and stained 
with TUNEL, acridine orange, or P53 antibody. 
TUNEL staining:  TUNEL staining was performed using Apoptag Red In 
Situ Apoptosis Detection Kit (#S7165, Chemicon International). Briefly, 
dissected imaginal discs were fixed in 4% paraformaldehyde, rinsed twice in 
PBTW (0.3% Tween-20 in 1X PBS) for 5 minutes/rinse, post-fixed in 2:1 
EtOH/1X PBS, rinsed again as before, and then incubated with equilibration 
buffer, TdT enzyme, and anti-digoxigenin Rhodamine congujate antibody in 
subsequent steps, according to manufacturer’s protocol. Finally, the discs were 
mounted in Vectashield (Vector Laboratories Inc., CA) and photographed. All 
images were at taken at 500 ms shutter speed and at neutral density 3. The 
minimum and maximum intensity ranges for TUNEL staining were set at 200 
and 2000, respectively, for all captured images. TUNEL fluorescence intensity 
was measured individually in the posterior and anterior compartments of each 
disc, normalized to the area of that compartment and expressed as integrated 
density of fluorescence intensity/area (InDen/area) in posterior compartment to 
that in the anterior compartment.  
Acridine orange staining:  Acridine orange staining was performed on 
freshly dissected imaginal discs. The discs were then incubated in a 1.6 x 10-6 M 
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solution of acridine orange (1.6 µl of 1mM solution of AO in 1 ml. Ringer’s 
solution) for 5 minutes, then mounted in Ringer’s solution and photographed 
immediately. All images were taken at 100 ms shutter speed and at neutral 
density 4. Minimum and maximum intensity range: 200-600. AO intensity is 
expressed as InD/area of the whole disc.  
P53 immunostaining:  Third instar larvae were dissected in 1X PBS and 
fixed in 4% paraformaldehyde for 15 minutes at room temperature. They were 
washed in PBTX (0.3% Triton-X in 1X PBS) twice for 30 minutes each, followed 
by 1 hour blocking in 5% BSA in PBTX. Next, they were incubated overnight at 
4°C in primary antibody, p53-7A4 (DSHB, University of Iowa, IA) at 1:10 
concentration in 5% BSA. The discs were then rinsed twice with PBTX, 30 
minutes each and once in blocking buffer for 1 hour and finally incubated with 
Alexa Fluor® 568 goat anti-mouse secondary antibody (Invitrogen, OR) at 1: 
1000 concentration for 2 hours. Finally, they were washed twice with PBTX as 
before and mounted in Vectashield (Vector Laboratories Inc., CA). All images 
were taken at 100 ms shutter speed and at neutral density 3. Minimum and 
maximum intensity range: 200-550. P53 staining intensity is expressed as 
InD/area where the area of only the region behind the morphogenetic furrow is 
considered.  
All fluorescent images were z stacks taken using an inverted Olympus 
IX2-DSU spinning disc confocal microscope, a Hamamatsu Orca-ER digital 
camera, and SLIDEBOOK software (Intelligent Imaging Innovations, CA). 
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dsRNA synthesis.  To synthesize double-stranded RNA for RNA 
interference experiments with cultured cells, PCR products not more than 700 
base pairs were made of the cDNA of interest flanked by T7 RNA polymerase 
sites at both ends. After gel purification of the PCR product, it was used as 
template for in vitro transcription for 6 hours at 37°C in a circulating water bath in 
5-6 replicates of 20 µl reaction each for better yield using Ambion Megascript® T7 
Transcription Kit (Life Technologies), according to manufacturer’s protocol. Then, 
the reactions were pooled together in a microcentrifuge tube and extracted with 
phenol-chloroform and chloroform. Finally, dsRNA was precipitated with 
ispropanol, dissolved in DEPC-treated H2O, and quantified in a Nanodrop 1000 
spectrophotometer (Thermo Scientific).  
 Primers used for obtaining PCR products were: Fwd_T7corp: 
5’TTAATACGACTCACTATAGGGAGAATGGCCGATATCAGGAGCAG3’; 
Rev_T7corp: 
5’TTAATACGACTCACTATAGGGAGACTAGATGCGAATCGAGCGCA3’; 
Fwd_T7p53: 
5’TTAATACGACTCACTATAGGGAGAAGATCCAGGCGAACACGCTG3’; 
Rev_T7p53: 
5’TTAATACGACTCACTATAGGGAGAGGCTTCCGGCACGGACTTG3’;  
Fwd_T7Pav: 
5’TTAATACGACTCACTATAGGGAGAACAACTGCTCTTGGCAGATACC3’; 
Rev_T7Pav: 
5’TTAATACGACTCACTATAGGGAGAAAATCCGTAACGAAACTAACCG3’. 
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Detection of P53 levels in S2 cells. 
Cell culture and dsRNA treatment.  S2 cells were cultured at 25°C in 
Schneider’s Drosophila Medium (Invitrogen) with 10% heat inactivated fetal 
bovine serum (HyClone) and 1X Antibiotic-Antimycotic (Invitrogen). Cells were 
passaged into fresh medium every 3-4 days and were discarded after passage 
25 (P25).  
The dsRNA treatment protocol was performed as described 61. Cells were 
passaged on day 0 at the rate of 2 x 106 cells/ml. On day 1, they were washed 
and seeded in 24-well plates at 800 µl/well. 15 µg of dsRNA was added to each 
well. The plates were then returned to the 25°C incubator. On day 4-5, cells were 
re-seeded in 6-well plates at 2 ml/well and retreated with 30 µg of dsRNA. As a 
control of dsRNA uptake rate, cells were treated with Pavarotti dsRNA, which 
makes them large and multinucleate 62,63. On day 6-7, cells were collected, lysed, 
and processed for Western blot. 
S2 cells, with or without dsRNA treatment, were irradiated at 4000 rads to 
observe any elevation/change in P53 levels from unirradiated cells, with or 
without dsRNA treatment. No significant changes in P53 levels were observed 
following irradiation, so treated cells were grouped and categorized as (I) no 
dsRNA control group and (II) + dsRNA experimental group for quantification.  
Western blotting.  Cells were collected and lysed in RIPA buffer 
containing protease inhibitor (Thermo Scientific, IL) to a final concentration of 1X. 
Protein concentration was measured by BCA assay (Thermo Scientific, IL) and 
cell lysates were mixed with sample buffer and β–mercaptoethanol to a final 
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concentration of 1X before loading onto a 10% SDS gel at equal concentrations. 
Western blotting was carried out following standard procedure. Antibodies used: 
mouse monoclonal anti-Drosophila P53 (# sc-74573, Santa Cruz Biotechnology; 
as used by Chen et al.54) at 1:1000 concentration and mouse monoclonal anti-
Drosophila β–tubulin (E7, Developmental Studies Hybridoma Bank, University of 
Iowa, IA) at 1:10,000 concentration. After incubation with fluorescent goat anti-
mouse secondary antibody (# 926-68020, Li-COR Biosciences) at 1:10,000, the 
membranes were scanned on an infrared Odyssey scanner (LI-COR 
Biosciences). The Western signals were quantified on the Li-COR scanner and 
the results from 6 independent experiments were averaged. Of these 6 
experiments, 2 were following irradiation at 4000 rads and allowing 4 hours 
recovery before cell lysis. Relative P53 levels in each experiment were calculated 
by normalizing total P53 protein level to total β–tubulin level. 
Protein interaction assays.  
Purification of GST and GST-DmP53.  The open reading frame of 
DmP53 was cloned into pGEX and transformed to BL21 DE3 cells. The 
expression was induced by addition of IPTG to a final concentration of 0.1mM in 
LB/Ampicillin media. Bacterial cells were harvested 4 hours following the 
induction and resuspended in ice-cold STE buffer (10mM Tris-HCl pH8.0, 
150mM NaCl, 1mM EDTA, and protease inhibitors) with 1.5% Sarcosyl. Cells 
were then lysed with sonication and subsequently incubated with STE containing 
1% Triton X-100 for 30 minutes. Insoluble proteins were removed by 
centrifugation at 16,000g for 5 minutes. Supernatant was then incubated 
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overnight with 50% slurry of glutathione-agarose beads at 4°C. The beads were 
pelleted by centrifuge at 100g and washed 4 more times with 10 ml of ice-cold 
PBTP (PBS with 0.1% Triton X-100 and protease inhibitors). Washed beads 
were then resuspended in PBTP with 0.01% sodium azide. 
Expression of Corp-GFPFlag in HeLa cells.  15ug of pRK5-corp-gfp-flag 
plasmid DNA was transfected to 2 million HeLa cells with calcium phosphate. 
Cells were lysed on plate with 1ml RIPA buffer at 48 hours following transfection.   
In vitro synthesis of Corp-HA6His.  Corp-HA6His was cloned into 
pCDNA3. In vitro synthesis were carried out using the TnT® Coupled 
Reticulocyte Lysate Systems (Promega, Catalog number L4611) following 
manufacturer’s instructions.  
GST pull-down assays.  For in vitro synthesized protein, 1 ug GST or 
GST-DmP53 bound to Glutathione-agarose beads was incubated with 5 ul of 
synthesized protein in 500ul Binding buffer (50mM Tris-HCl, pH 8.0; 2mM EDTA; 
150mM NaCl; 0.1% NP40; 20uM ZnCl2; 10mM MgCl2; protease inhibitors) 
containing BSA (0.2ug/ul). Following 1 hour incubation at RT and 1 hour 
incubation at 4oC, the beads were washed 4 times with Binding buffer.  Beads 
were then pelleted at 100g, re-suspended and boiled in 30 ul sampling buffer, 
and resolved on SDS-PAGE gel.  Following electrophoresis, the gel was fixed in 
(Isopropenol:dH2O:Acitic acid=25:65:10) for 30 minutes and incubated in the 
Amplify Fluorographic Reagent (GE Healthcare, NAMP100) for 1 hour.  The gel 
was then vacuum dried and processed for autoradiography with an intensify 
screen at -80oC.  
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For cellular extract, 1 ug GST or GST-DmP53 bound to Glutathione-
agarose beads was first incubated for 30 minutes in 500ul binding buffer with 
0.2ug/ul BSA.  500 ul cell lysate was then added and incubated at 4oC for 
overnight.  Following incubation, the beads were washed 4 times with 1 ml of 
RIPA buffer and pelleted by centrifugation at 100g for 5 minutes.  Beads were 
then resuspended in 30ul sampling buffer and resolved on SDS-PAGE gel.  
Western analysis was performed with anti-Flag M2 antibody (Sigma, F1804). 
Co-immunoprecipitation.  10ug of pRK5-corp-gfp-flag plasmid DNA and 
10ug of pEX-3B-hsp53-ha was transfected to 2 million HeLa cells with calcium 
phosphate.  At 48 hours post transfection, cells were lysed with RIPA buffer, 
precleared with protein G–Sepharose beads, and then incubated with anti-
Flag(M2) mouse monoclonal antibody for overnight at 4oC.  The immunocomplex 
was then precipitated with protein G- Sepharose beads, followed by SDS-PAGE 
and Western blot analysis. 
Graphical methods and statistical analyses.  Construction of graphs 
and calculations of statistical significance were performed using Prism 5.0 
(Graphpad). In box-and-whisker plots, the ends of whiskers represent 5th and 
95th percentiles, top and bottom of the boxes represent 25th and 75th percentile, 
and the horizontal line in the box represents the median, i.e., 50th percentile. The 
Mann-Whitney test was used in all cases except for Figure 5D, where a paired t-
test was used. 
Software.  The MEME tool used for searching motif similarity is publicly 
available software (http://meme.nbcr.net/meme/). Images were quantitatively 
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analyzed using IMAGE J software from National Institutes of Health 
(http://imagej.nih.gov/ij/index.html) and images were processed using Adobe 
Photoshop. All line diagrams were composed using Adobe Illustrator. 
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Figure 8. Overexpression of corp+ suppresses the BARTL phenotype.  
 (A) The range of eye phenotypes observed in the assay. The BS phenotype of 
H1 control males is shown at the left. When FLP is expressed (ey>FLP), the 
phenotypes can range from headless pharates (category 1) to adults with a fully 
developed wildtype eye (category 5). The distribution produced (B) in control 
males; (C) in males carrying P{EPgy2}EY03495, referred to as EP-corp+; (D) by 
inclusion of a UAS-corp+ transgene; (E) with RNAi-mediated knockdown of corp; 
(F) in corp95B mutants; and, (G) with rescue of the corp95B phenotype by 
expression from the UAS-corp+ transgene. N represents number of eyes scored 
for each genotype. Genotypes used are as follows: (B) y w/H1; eyGal4 UAS-
FLP/+; (C) y w EP-corp+/H1; eyGal4 UAS-FLP/+; (D) y w/H1; eyGal4 UAS-
FLP/+; UAS-corp+/+; (E) y w/H1; eyGal4 UAS-FLP/RNAi-corp; (F) y w 
corp95B/H1; eyGal4 UAS-FLP/+; (G) y w corp95B/H1; eyGal4 UAS-FLP/+; UAS-
corp+/+. 
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Figure 9. EP-corp+ induces corp+ overexpression.  
corp mRNA levels were measured by qRTPCR on total cDNA extracts from 
Actin-Gal4 EP-corp+ or y w control adults. The Y-axis indicates corp transcript 
levels normalized to the Rpl32 transcript. Data are represented as mean +SEM. 
N represents the number of biological replicates of each experiment. Statistical 
significance was calculated by the Mann-Whitney test. Although corp expression 
was ~15X higher when the EP-corp+ was driven, the difference was not 
significant at the 5% level. 
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Figure 10. Deletion mapping in the corp95B mutant.  
(A) The corp genomic region on the X chromosome and corp transcripts (RA and 
RB; adapted from FlyBase: http://flybase.org/reports/FBgn0030028.html). 
Orange shading denotes the protein coding regions. The blue arrowhead 
indicates the site of the EY03495 EPgy2. Imprecise excision of the EY03495 
element produced the corp95B allele. The black line indicates the region of the 
genome that is deleted in corp95B mutant. Two sets of primers, Fwd1, Rev1 and 
Fwd2, Rev2 were used for PCR amplification of corp genomic region.  
(B,C) Visualization of PCR results. The corp genomic region was amplified either 
by Fwd1, Rev1 or by Fwd 2, Rev2 primer pairs in four different genotypes, run in 
the four lanes on the gel, marked 1 through 4: (1) y w; (2) corp mutant 1; (3) 
corp95B; and (4) corp mutant 2. M1 is a 1 kb ladder and M2 is the 100 bp ladder. 
The vertical red arrow indicates the lane 3, which lacks any PCR product and 
corresponds to the corp95B template. The horizontal red arrowhead points to the 
size expected in the y w control. Only the corp95B mutant was used in this work. 
The extent of the corp95B deletion allele was determined by DNA sequencing of 
genomic DNA. 
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Figure 11. Altered corp function only affects eyes after dicentric 
chromosome induction.  
The distribution of eye sizes when (B) H1 dicentrics are produced in the 
presence of uninduced EP-corp+; (C) EP-corp+ is induced in B+ flies without 
dicentric induction; (D, E) EP-corp+ is introduced, uninduced (D), and induced 
(E) into BS flies without dicentric induction; (F) corp95B is introduced into BS 
background without dicentric induction; (G) corp95B is introduced into B+ flies 
without dicentric induction; (H) H1 dicentrics are produced in XXY(H1) females; 
(I) EP-corp+ is overexpressed following dicentric induction in XXY(H1) females; 
(J) dicentric chromosome formation is induced on chromosome 3 (Dc3); and (K) 
EP-corp+ is overexpressed with chromosome 3 dicentric induction (K). N 
represents the number of fly eyes scored for each genotype. 
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Figure 12. corp+ inhibits DNA damage-induced apoptosis in somatic 
tissue.  
(A) The effect of corp+ overexpression assayed by TUNEL staining of third instar 
wing discs 3 hours after exposure to 4000 rads of IR. The white broken line 
marks the boundary between the anterior (ant) and posterior (post) 
compartments of the disc, based on engrailed-driven GFP fluorescence that 
marks the posterior compartment (i and iii). (i, ii) The staining pattern in wildtype 
control. (iii, iv) Staining in discs where engrailed is driving EP-corp+ 
overexpression in posterior compartment. TUNEL staining is very dense in 
wildtype larvae in the posterior segment (ii), but is greatly reduced with corp+ 
overexpression (iv). All images were taken with a 20X objective.  
(B) The effect of the corp95B mutant assayed by acridine orange (AO) staining of 
wing discs from irradiated third instar larvae. Larvae were exposed to 4000 rads 
of X-ray and dissected 5-6 hours later. Staining is greatly increased in corp95B 
mutants compared to the y w control. Images were captured with a 10X 
objective. Representative discs are shown here as negative images for ease of 
visualization. 
(C) Quantitation of TUNEL staining. The ratio of posterior:anterior fluorescence 
intensity in each disc was used as a measure of how corp+ overexpression 
alters apoptosis. Genotypes tested are indicated on the X-axis. N represents 
total number of discs used for quantification.  
(D) Quantitation of AO staining. Staining intensity per unit area for y w control 
and corp95B mutant. N represents total number of discs used for quantification.  
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Figure 13. Interaction of corp and p53.  
(A) The p535A-1-4 mutation is epistatic to corp in the BARTL assay. The corp95B 
mutation produces headless flies in the BARTL assay (reproduced from Figure 
2), while p535A-1-4 has the opposite effect, producing flies with wildtype eyes. The 
double mutant is indistinguishable from the p535A-1-4 single mutant. N represents 
the number of eyes or headless pharates scored. Genotypes used were y w 
corp95B/H1; eyGal4 UAS-FLP; y w/H1; eyGal4 UAS-FLP/+; p535A-1-4 ; y w 
corp95B/H1; eyGal4 UAS-FLP/+; p535A-1-. 
(B) Overexpression of corp+ suppresses the apoptotic phenotype caused by 
overexpression of p53+. Eye sizes were measured from flies that overexpressed 
p53+, and that also overexpressed corp+ or were corp95B mutants. The Y-axis 
represents fraction of wildtype eye size. N is the number of eyes measured.  
(C) corp+ overexpression suppresses the cell-death phenotypes mediated by 
hid+ or reaper+ overexpression. GMR drives corp+, hid+, and reaper+ 
overexpression. The Y-axis represents eye size, normalized to wildtype, for 
each genotype. N is the number of eyes. 
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Figure 14. Corp negatively regulates P53 protein levels.  
(A) Immunostaining of eye discs of flies expressing p53+ under control of the 
GMR promoter (shown here as negative images). Red arrowheads indicate 
approximate position of the morphogenetic furrow. Posterior is to the right. 
Genotypes are as indicated. All images were taken with a 40X objective.  
(B) Quantitation of P53 immunostaining. N represents the number of eye discs 
scored.  
(C, D) P53 protein level increases in corp knockdown cells.  
(C) Western blot of protein extracts from S2 cells. The first lane represents 
untreated cells (WT), and the second lane after treatment with dsRNA directed 
against corp. β–tubulin is the loading control. Blots are cropped to display only 
the desired sizes for clarity and conciseness of data presentation. 
(D) Quantitation of P53 protein levels. P53 protein levels are represented as the 
P53 protein level normalized to β–tubulin. N represents the number of 
experimental repetitions. Data are represented as mean +SEM.  
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Figure 15. corp+ does not affect p53 transcript levels. 
p53 mRNA levels were measured by qRTPCR on total cDNA extracts of 
irradiated and nonirradiated third instar larvae. The graphs represent p53 mRNA 
levels with no irradiation and at different time points after irradiation, in control 
(light blue bars) corp+ overexpressing (yellow bars) and corp95B mutant (pink 
bars) larvae (as indicated). The larvae were irradiated at 4000 rads and allowed 
to recover for 1, 2, and 3 hours before cDNA extraction. Three biological 
replicates were carried out for each experiment. Data are represented as mean 
+/- SEM. 
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Figure 16. Relationships between Corp, Mdm2, and P53. 
(A) Conserved protein motifs between Mdm2 and Corp identified by MEME. 
Seven similar protein motifs between 4 vertebrate Mdm2 orthologs (H. sapiens, 
M. musculus, D. rerio, G. gallus) and 2 Corp orthologs (D. melanogaster, D. 
virlis). Two motifs are conserved between Mdm2 and Corp in all six species.  
(i) A complete map of the 6 proteins indicating 7 shared motifs, represented by 
colored rectangles. A scale below indicates length of the individual proteins. 
Motifs 4 and 5 are found in Corp. (ii) The amino acid sequence of motif 4. Start 
site indicates the first amino acid residue in that motif. Amino acids of conserved 
motifs are color-coded 64. P-values that indicate the significance of conservation 
of each motif were produced by MEME. (iii) The amino acid sequence of the 
motif 5 region.  
 (B) A model of the pro-apoptotic and anti-apoptotic pathways under P53 control 
in Drosophila melanogaster. A DNA double-strand break activates the DNA 
damage response leading to P53 activation. The well-known pro-apoptotic 
genes hid and reaper are indicated in one pathway downstream from P53, while 
the anti-apoptotic gene corp is diagrammed in a second branch of the pathway. 
Hid and Reaper inhibit the inhibitor of apoptosis Diap1, thus triggering the 
downstream initiator and effector caspases, Dronc and Drice, respectively, to 
induce apoptosis. A positive feedback loop acting on p53 exists downstream of 
hid and reaper. Corp constitutes a second feedback loop, in this case acting 
negatively on P53.  
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Figure 17. Corp physically interacts with Drosophila P53.  
(A) The results of pull-down from HeLa cells expressing Corp-GFPFlag. Cell 
lysate was incubated with GST or GST-DmP53 bound to glutathione-agarose 
beads. Captured proteins were resolved with SDS-PAGE and probed with anti-
Flag antibody. The predicted molecular weight of Corp-GFPFlag is about 55 
KDa. The smaller (~33KDa) band on the input lane likely reflects the C-terminal 
fragment of the fusion protein, which does not interact with GST-DmP53.  
(B) In vitro synthesized Corp-HA6His (~28KDa) interacts with GST-DmP53.  The 
smaller band likely reflects an N-terminal 35S-Methionine containing fragment of 
Corp, which does interact with DmP53.  
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Figure 18. Protein interactions of Corp in Drosophila melanogaster. 
This figure, taken from FlyBase (http://flybase.org/cgi-
bin/get_interactions.html?items=FBgn0030028&mode=ppi), shows proteins that 
have been identified as physically interacting with Corp 1. Nine of these 19 
interactors are proteasome subunits. 
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Table 5. Effect of corp on transmission of broken-and-healed 
chromosomes through the male germline. 
 
Genotype Na Sterility 
(%)b 
FrY 
sons 
Y sons Fragment 
Ratioc 
(P value) 
Daughters 
 
y w/H1; 
70FLP10/+ 
 
317 
 
55 
 
6401 
 
14411 
 
0.31 
 
25011 
 
y w EP-corp+/H1;  
70FLP10/+; 
nosGal4/+ 
 
 
247 
 
51 
 
7 
 
9801 
 
0.001 
(P<0.000
1) 
 
11611 
y w/H1;  
UAS-FLP 
nosGal4/+ 
 
247 14 11998 2425 0.83 16675 
y w EP-corp+/H1; 
UAS-FLP 
nosGal4/+ 
  
174 30 2180 7573 0.22 
(P<0.000
1) 
11386 
a N, number of males testcrossed. 
b Percentage of tested males that were sterile. 
c Fragment ratio is calculated as FrY sons/total sons. P values were determined 
with the Mann-Whitney test using Fragment Ratios of individual males. Each P 
value represents comparison with the row immediately above in this table. 
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ROLE OF FS(1)YB AS AN INDUCER OF CELL DEATH 
FOLLOWING IRREPARABLE DNA DAMAGE 
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Abstract 
The EP misexpression screen in the BARTL background identified a gene, 
fs(1)Yb, that severely reduces cell survival following irreparable DNA damage in 
the form of a telomere loss, leading to the ablation of the whole tissue. fs(1)Yb 
knockdown, on the other hand, reduces the severity of apoptotic phenotype. 
fs(1)Yb is an upstream component in the piwi/piRNA pathway that plays an 
essential role in germline stem cell maintenance by inducing piRNA generation 
and transposon silencing through the downstream components, armi and piwi. 
Though the function of armi in suppression of DNA damage response and that of 
both armi and piwi in maintenance of telomere integrity have been previous 
reported, the role of fs(1)Yb in response to DNA damage has not been studied. 
Our results indicate a possible role of fs(1)Yb in the induction of DDR pathway 
following telomere loss.  
 
Introduction 
The fs(1)Yb gene was originally uncovered by mutations that caused 
semi-sterility in females of Drosophila melanogaster (Young and Judd, 1978).  
Later, it was determined that fs(1)Yb plays an essential role in germline stem cell 
maintenance, particularly during differentiation of ovarian follicle cells. Yb 
mutants produce few or no eggs (Johnson et al., 1995; King and Lin, 1999; 
Szakmary et al., 2009). The female sterility caused by fs(1)Yb was partially 
suppressed by increasing the Notch dosage, while reduction of Notch dosage 
produced a more severe phenotype, suggesting a possible functional or 
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regulatory interplay between fs(1)Yb and Notch signaling during oogenesis 
(Johnson et al., 1995).  
Later, Yb was characterized as a major upstream component of the 
piwi/piRNA pathway (King et al., 2001; Qi et al., 2011). The complex class of 
small noncoding RNAs, called piRNAs, that interact with Piwi proteins have been 
widely implicated for their germline-specific roles in stem cell maintenance, 
spermiogenesis, and transposon silencing (Cox et al., 1998; Megosh et al., 2006; 
Szakmary et al., 2009; Thomson and Lin, 2009). Structural analysis revealed that 
Fs(1)Yb contains a TUDOR domain, which is present in most piRNA pathway 
proteins (King and Lin, 1999; Shoji et al., 2009). Fs(1)Yb localizes to dense 
cytoplasmic regions called Yb bodies where it recruits armitage (Armi), a putative 
RNA helicase involved in the piRNA pathway, and recruits Piwi, another piRNA 
component, into the nucleus of somatic and germ cells, where Piwi then silences 
genes by piRNA generation. In Yb mutants, the co-immunoprecipitation of Armi 
with Yb is disrupted, Piwi fails to enter the nucleus and is freed from piRNAs, 
which then get drastically diminished, and somatic transposons are desilenced 
(Qi et al., 2011; Saito et al., 2010). Thus, fs(1)Yb poses to be an upstream piRNA 
pathway component and plays a crucial role in monitoring the Piwi-piRNA binding 
and eventual transposon silencing. There are two parallel pathways downstream 
of fs(1)Yb: the piwi-mediated germline stem cell self-renewal and the hedgehog 
(hh)-mediated somatic stem cell proliferation. Via these pathways, fs(1)Yb 
maintains both the germline and somatic stem cell populations. Yb mutants 
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eliminate and Yb+ overexpression overproliferates both stem cell populations 
(King et al., 2001).  
Piwi-pathway proteins have been shown to play an important role in 
maintenance of telomere integrity. This is achieved by silencing the transcription 
of telomeric repeat sequences and maintaining the telomeric capping complex. In 
fact, armi mutants have been shown to disrupt HOAP binding to telomere, reduce 
expression of a subpopulation of telomere-specific piRNAs, and enhance HeT-A 
copy numbers. armi mutants also lead to extensive fragmentation of the zygotic 
genome (Khurana et al., 2010), probably due to DNA damage signaling from 
genome-wide over-transcription. Furthermore, mutations of piRNA pathway 
proteins, like armi and aub, have developmental implications in the context of 
DNA damage response. They result in disruption of asymmetric RNA localization 
along the axes of the oocyte, which is rescued by chk2 mutants (Chen et al., 
2007; Klattenhoff et al., 2007), implying that mutation of piRNA pathway proteins 
triggers DNA damage response at their downstream, which is suppressed by 
mutating damage response pathway proteins, for example, chk2. All these 
evidences point to the fact that disruption of piRNA pathway proteins can be the 
causative agent of DNA damage, which induces the responses downstream to it. 
However, there has been no report so far on the role of fs(1)Yb in DNA 
damage response. Here, we demonstrate that fs(1)Yb+ acts as an enhancer of 
cell-death phenotype in the soma following telomere loss, probably through 
elimination of cells with telomere loss in a P53-dependent manner. It also 
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eliminates germline cells that have been induced with telomere loss and inhibits 
transmission of broken-and-healed chromosome through the germline.  
 
Results 
EP misexpression screen identifies fs(1)Yb as an enhancer of 
apoptosis phenotype following irreparable DNA damage.  Through the EP 
misexpression screen in the BARTL background (Kurzhals et al., 2011), we 
identified an EP insertion, P{EPgy2}CG2701EY04983, that produced headless 
pharates in the BARTL assay (Figure 19C). This insertion was ideally placed to 
drive expression of the fs(1)Yb+ gene (CG2706) (Figure 20A). When we tested 
RNAi-mediated knockdown of fs(1)Yb in the BARTL assay, an opposite result 
was obtained: the eyes were significantly larger, though not fully wildtype-like 
(Figure 19E,F). Similarly, a fs(1)Yb null mutant gave mostly large eyes when 
tested in the BARTL background (Figure 19D). If EP-fs(1)Yb+ was not induced by 
Gal4, and eyFLP was instead used to produce dicentric chromosomes in the eye, 
we found that the EP-fs(1)Yb+ insertion, by itself, had no effect (Figure 19J). This 
further confirms that fs(1)Yb+ overexpression is necessary to generate the large 
eye phenotype in the BARTL assay. 
To determine whether fs(1)Yb has any influence in the absence of DNA 
damage, we examined wildtype or BS flies carrying EP-fs(1)Yb+, induced or 
uninduced, but without the induction of dicentric chromosomes. There was 
mostly no change in eye phenotype in any of these cases, indicating that the 
effects of altered fs(1)Yb expression are seen only after DNA damage (Figure 
 107 
19G-I).  
EP-corp+ suppresses the apoptotic phenotype of EP-fs(1)Yb+ 
following telomere loss.  We have previously identified corp as one of the 
genes in the EP screen that displayed a suppressor effect in the BARTL assay 
and have demonstrated that corp acts as a negative regulator of the tumor 
suppressor P53 (Chapter 2 and 3). We wanted to find out if corp and fs(1)Yb act 
in the same or in a complementary pathway in response to DNA damage. So, we 
overexpressed both fs(1)Yb+ and corp+, mediated by EP, in the BARTL 
background. This recovered adults with wildtype-like eyes (Figure 20B-D), 
suggesting that corp acts downstream of fs(1)Yb following DNA damage to 
rescue the cell-death phenotype produced by fs(1)Yb. This further implies that it 
functions upstream of p53, therefore in the DDR pathway.  
EP-induced fs(1)Yb overexpression inhibits germline transmission of 
broken and healed chromosomes.  Since EP-fs(1)Yb+  produced an apoptotic 
phenotype in the somatic tissue following telomere loss, we wanted to investigate 
if it also eliminates cells after telomere loss in the germline. We have previously 
seen that if a germline cell suffers a telomere loss, that chromosome may be 
healed by addition of a telomere cap, and then transmitted to progeny (Ahmad 
and Golic, 1998; Titen and Golic, 2010). In order to find out if EP-fs(1)Yb+ affects 
the transmission of broken-and-healed chromosome, we induced expression of 
FLP by heat shock (70FLP10) during the first 24 hours of development and used 
nanosGal4 to drive germ cell-specific overexpression of EP-fs(1)Yb+. We found 
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that EP-fs(1)Yb+ significantly reduced transmission of broken-and-healed 
chromosomes (Table 6).  
Overexpression of telomere cap component, hiphop, rescues the 
cell-death phenotype produced by EP-induced fs(1)Yb overexpression.  
Since EP-fs(1)Yb+ reduced transmission of broken-and-healed chromosomes, 
there is a possibility that it plays a role to inhibit the addition of de-novo telomeres 
at broken ends of chromosomes. If this holds true, then fs(1)Yb+ would likely 
disrupt the phenotype produced telomere capping components. In order to test 
this, we co-overexpressed EP-fs(1)Yb+  with a component of the telomere cap 
complex, hiphop. We found, as previously seen (R. Kurzhals, personal 
communication), that induction of UAS-hiphop+ produces near-wildtype eyes 
following telomere loss (Figure 20E). However, co-expression of fs(1)Yb+ 
produced no change in the phenotype (Figure 20F). This fails to demonstrate a 
role of fs(1)Yb+ in inhibition of de novo telomere addition.   
Knockdown of piwi pathway components induce an apoptotic 
phenotype independent of DNA damage induction.  Since fs(1)Yb is a 
component of the piRNA pathway, we wanted to test the piwi and armi genes for 
their role on cell survival following telomere loss. Interestingly, we found that 
knockdown of piwi and armi induced a cell-death phenotype, as opposed to 
fs(1)Yb knockdown (Table 7). To determine whether they have a general effect 
on eye development, we induced piwi and armi knockdown in a wildtype 
background without induction of telomere loss. We found that knockdown of piwi 
or armi reduced cell survival in the eye even without any DNA damage induction, 
 109 
implying that their loss hinders normal eye development and that this effect is 
aggravated after induction of DNA damage to the cells of the eye.  
 
Discussion and future directions 
In the BARTL assay, fs(1)Yb overexpression and knockdown produced 
drastically opposite phenotypes: fs(1)Yb overexpression ablated the eye 
completely following telomere loss while the Yb mutant and knockdowns 
produced significantly enlarged eyes. This suggests that fs(1)Yb normally makes 
only a small contribution to the elimination of cells with DNA damage, or that the 
RNA interference is not highly effective; however, its overexpression in the 
somatic cells is clearly capable of mediating the death of virtually all cells with 
irreparable DNA damage. Similar to the effect in soma, fs(1)Yb overexpression 
increases the elimination of cells with broken chromosomes in the germline, seen 
as reduced transmission of broken-and-healed chromosomes through the 
germline. This could have suggested a possible role of fs(1)Yb+ in inhibition of de 
novo telomere addition. However, our finding, that fs(1)Yb+ overexpression does 
not alter the large eye phenotype produced by hiphop+ overexpression in the 
BARTL assay, indicates a declined probability of its role in inhibition of de novo 
telomere capping. The fact that fs(1)Yb+ inhibits broken-and-healed chromosome 
transmission but not a significant change in sex ratio, compared to the wildtypes 
carrying a broken chromosome, suggests that fs(1)Yb+ plays a role in controlling 
the survival of germline cells with a broken chromosome: it aids the elimination of 
primary spermatocytes with an unhealed damaged chromosome at the 16 cell-
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stage, but not of the post-meiotic FrY spermatids - that results in the decrease in 
fragment transmission but not a significant difference in the sex ratio. It was also 
interesting to note a sharp drop in the average number of progenies produced by 
each fertile male carrying a broken chromosome and with fs(1)Yb+ 
overexpression in its germline. This may be due to the fact a large number of 
primary spermatocytes are eliminated by fs(1)Yb+. However, since the 
experiment was carried out in different ways (total number of progenies were 
scored from two vials for each wildtype tester male and the progenies scored for 
fs(1)Yb+ overexpressing tester males were obtained from one vial), prediction 
cannot be made based on these numbers. Still, if we halve the average number 
of progenies produced by the wildtype (that is, 145 progenies on an average), it 
is still about three folds more than those produced by the fs(1)Yb+ 
overexpressing testers (50 progenies on an average). Nevertheless, this is not 
reliable and so, this experiment would be carried out in a similar setup, using 
UAS-FLP nanosGal4-mediated dicentric formation in the germline. The 
hypothesis, that fs(1)Yb+ is eliminating cells with broken chromosome at a pre-
meiotic stage, can be tested by dissecting out testes from newly eclosed adult 
tester males with fs(1)Yb+ overexpression and scoring the population of primary 
spermatocytes within single cysts over a time course after dicentric induction. I 
predict to find a decrease in the number of primary spermatocytes in fs(1)Yb+ 
overexpressing males, compared to wildtype.  
One way by which fs(1)Yb+ may act is by inducing the DDR pathway at its 
downstream. In support, we found that corp+ overexpression alleviates the 
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BARTL phenotype produced by fs(1)Yb+ overexpression. This can be interpreted 
as, fs(1)Yb+ overexpression induces a P53-dependent cell death following DNA 
damage, which is rescued through corp+ overexpression. Alternatively, it may 
also suggest that corp acts through a pathway independent of fs(1)Yb, yet 
interferes, somewhere downstream, with fs(1)Yb-mediated induction of apoptotic 
phenotype. In order to find out if fs(1)Yb+ induces apoptotic phenotype in a P53-
dependent manner, a BARTL assay of EP-fs(1)Yb+ in a p535A-1-4 background can 
be carried out. Here, I would expect to observe a rescue of eye phenotype, 
producing large to wildtype-like eyes. To further investigate where exactly does 
fs(1)Yb+ fits in the DDR pathway, a BARTL assay of EP-fs(1)Yb+ can be carried 
out in a chk2-/- background. Further, to study if EP-fs(1)Yb+-mediated 
overexpression induces apoptosis, TUNEL or acridine orange staining of 
imaginal discs of irradiated fs(1)Yb+ overexpressing larvae can be performed. 
 
Methods and materials 
Drosophila stock collections.  The Bloomington stocks obtained were:  
P{EPgy2}CG2701EY04983 (BL15778), RNAi-fs(1)Yb (BL 35301 and BL 35181), 
RNAi-piwi (BL 34866 and BL 33724), RNAi-armi (BL 34789), P{Gal4-ey.H}4-8 
(BL 5535), P{eyFLP.N}5 (BL5576), P{EPgy2}CG1632EY03495 (BL 15650). 
DcY(H1) (Kurzhals et al., 2011), eGUF4.8JD1, w; 70FLP10, and UAS-
hiphop(HRH008H) were obtained from our laboratory stock collection. The Yb72 
stock was kindly gifted by Dr. Haifan Lin.  
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Germline fragment chromosome transmission assay.  Flies were 
allowed to lay eggs and transferred to fresh vials every day. Embryos were 
collected for 24 hrs, heat-shocked at 38°C for 1 hour in a circulating water bath, 
and then immediately returned to 25°C. After eclosion, the males were collected 
and singly mated to 2-3 y w females and their progeny were scored. 
Graphical methods and statistical analyses.  Construction of graphs 
and calculations of statistical significance were performed using Prism 5.0 
(Graphpad). The Mann-Whitney test was used.  
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Figure 19. Overexpression of fs(1)Yb+ suppresses the BARTL phenotype 
only after telomere loss. (A) The eye phenotype distribution observed in the 
BARTL assay. The BS phenotype of H1 control males is shown at the left. When 
FLP is expressed (ey>FLP), the phenotypes can range from headless pharates 
(category 1) to adults with a fully developed wildtype eye (category 5). The 
distribution produced (B) in control males following dicentric induction by 
eGUF4.8JD1; (C) in males carrying P{EPgy2}EY04983 (BL 15778); (D) in 
fs(1)Yb72 mutants; (E, F) RNAi-mediated knockdowns of fs(1)Yb; (G, H) when 
EP-fs(1)Yb+ is introduced, uninduced (G) and induced (H) into BS flies without 
dicentric induction; (I) when EP-fs(1)Yb+ is induced in B+ flies without dicentric 
induction; (J) when H1 dicentrics are produced in the presence of uninduced 
EP-fs(1)Yb+. N represents number of eyes or headless pharates scored for each 
genotype. 
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Figure 20. Effect of corp+ and hiphop+ overexpression on fs(1)Yb+-
mediated apoptotic phenotype in the BARTL assay. (A) The fs(1)Yb genomic 
region on the X chromosome and fs(1)Yb transcripts, fs(1)Yb-RA (adapted from 
FlyBase: 
http://flybase.org/cgibin/gbrowse2/dmel/?Search=1;name=FBgn0000928). 
Orange shading denotes the protein coding regions and grey shading denotes 
the 5’ and 3’ UTR regions on the fs(1)Yb transcript. The blue arrowhead, 
highlighted by an orange rectangle, indicates the site of the EY04983 EPgy2 
insertion. (B) The EP-fs(1)Yb+ produces headless pharates in the BARTL assay 
(reproduced from Figure 14), while (C) EP-corp+ has the opposite effect, 
producing flies with wildtype eyes. (D) Co-induction of both is indistinguishable 
from the EP-corp+-mediated overexpression. (E) hiphop+ overexpression 
produces and wildtype eyes and (F) co-induction of both fs(1)Yb+ and hiphop+ is 
indistinguishable from the hiphop+ overexpression alone. N represents the 
number of eyes or headless pharates scored.  
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Table 6. Effect of fs(1)Yb+ on transmission of broken-and-healed 
chromosomes through the male germline. 
 
Genotype Na Sterili
ty 
(%)b 
FrY 
sons 
Y 
sons 
Fragment 
Ratioc 
(P value) 
Daughters Sex    
ratio Progenyavg
d
 
 
y w/H1; 
70FLP10/+ 
 
 
341 
 
 
53 
 
6470 
 
14727 
 
0.31 
 
25476 
 
0.83 
 
291 
 
 
y w EP-
fs(1)Yb+/H1;  
70FLP10/+; 
nosGal4/+ 
 
 
 
363 
 
 
 
26 
 
 
901 
 
 
5540 
 
 
0.14 
(P<0.0001) 
 
 
7208 
 
 
0.89 
 
 
50 
hjky w EP-
fs(1)Yb+/H1;  
70FLP10/+; 
nosGal4/+ 
 
(no heat-
shock 
control) 
 
 
 
15 
 
 
 
20 
 
 
0 
 
 
476 
 
 
0.0 
 
 
 
528 
 
 
0.90 
 
 
84 
a N, number of males testcrossed. 
b Percentage of tested males that were sterile. 
c Fragment ratio is calculated as FrY sons/total sons. P values were determined 
with the Mann-Whitney test using Fragment Ratios of individual males. The P 
value represents comparison with the row immediately above in this table. 
d Average number of progenies (male+female) produced by each fertile tester 
male. 
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Table 7. Effect of piwi and armi knockdowns/amorphic alleles on BARTL 
phenotype and on BS eye phenotype without telomere loss.   
 
 
Crossed to y w/H1; eGUF4.8JD1 (telomere loss) 
 
Effected 
gene 
RNAi/ 
amorphic 
allelea 
Nb BARTL phenotype (%)c 
BS 1 2 3 4 5 
piwi BL 34866 40 0 100 0 0 0 0 
BL 33724 42 0 92 0 0 4 4 
armi BL 34789 55 0 50 7 7 2 34 
   
Crossed to y w/Y; eyGal4-4.8 (without telomere loss) 
 
piwi BL 34866 36 0 100 0 0 0 0 
BL 33724 52 0 0 0 0 50 50 
armi BL 34789 42 0 0 10 10 2 78 
 
a RNAi and amorphic stocks are obtained from Bloomington Stock Center (BL). 
b Numbers of flies scored. 
c The range of BARTL eye phenotypes are categorized as either BS or from no 
eye (category 1) to full grown eye (category 5), as depicted in Figure 14A.  
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Abstract 
Viability to high doses of ionizing radiation was investigated In Drosophila 
melanogaster. Stocks with comparatively clearer genetic backgrounds, derived 
from the original wildtype laboratory strain showed variable sensitivity to X-ray 
dose. Females survived better than males following irradiation. The viability of 
the organisms decreased significantly in a p53 mutant. Interestingly, a corp 
mutant exhibited a similar effect to the p53 mutant, that is, decreased organismal 
viability following irradiation. corp+ overexpression significantly increased their 
survival rate, particularly in males.  
 
Introduction 
Ionizing irradiation is a widely used method for inducing DNA damage to 
cells and as a leading anticancer therapy. Organisms are regularly exposed to 
radiation naturally and thus have evolved mechanisms to survive its detrimental 
effects. Irradiation causes DNA damage and genomic instability primarily by 
inducing double-strand breaks, and cells respond to it by activating checkpoints 
to induce cell cycle arrest and DNA repair, and to trigger apoptosis if the damage 
is beyond repair (Jackson and Bartek, 2009; Morgan et al., 1996; Sancar et al., 
2004; Zhou and Elledge, 2000). These response pathways serve the critical 
function of maintaining genomic integrity, since widespread genetic instability and 
abnormality can lead to development of cancer in mammals.  
It has been reported that DNA repair is extremely essential for surviving 
irradiation; cell cycle regulation and apoptosis are neither indispensable nor 
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sufficient (Jaklevic et al., 2006; Jaklevic and Su, 2004). mei-41 (DmATR) and 
okra (DmRad54) mutants that are deficient in DNA repair die as pupae following 
irradiation, whereas a grp (DmChk1) mutant that can repair DNA damage but 
cannot regulate the cell cycle does not. This is possibly because, if cells continue 
to survive and proliferate with unrepaired DNA, the aberrations spread to the 
daughter cells and is unhealthy for the organism as a whole. To ensure 
organismal survival following radiation exposure, cell cycle progression is 
delayed and repair of DNA breaks commences. Unrepaired cells are removed by 
apoptosis and compensatory proliferation produces additional cells to maintain 
tissue integrity and organismal viability (Jaklevic and Su, 2004).  
The p53 tumor suppressor gene is one of the central players that govern 
adaptive responses to stress and is found to be mutated in most forms of human 
cancers (Hollstein et al., 1991; Vousden and Lu, 2002). It mediates 
transcriptional activation of genes that function in DNA repair and apoptosis. p53 
mutants have been found to be sensitive to doses of irradiation (Jaklevic et al., 
2006; Jaklevic and Su, 2004; Sogame et al., 2003). This may be because, even 
though cells are escaping apoptosis in a p53 mutant following DNA damage, they 
ultimately die through other stress pathway activation (McNamee and Brodsky, 
2009; Titen and Golic, 2008; van Bergeijk et al., 2012; Wichmann et al., 2006) 
due to a heavy load of unrepaired DNA damage in these cells. As a result, the 
tissue integrity is lost and the organisms fail to survive. 
Here we report that, when tested for their ability to survive a high 
irradiation dose, stocks with a lesser degree of background genetic variability, 
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derived from original wildtype laboratory strain, exhibited variable rates of 
sensitivity between themselves. We found that a corp mutant becomes sensitive, 
similar to the p53 mutant, and that corp+ overexpression induces resistance to 
irradiation in males.  
 
Results and discussion 
The original wildtype laboratory strain, y w, is extremely sensitive to 
irradiation.  When individuals from our control laboratory strain, y w, were 
irradiated with 4000 rad of X-ray as third instar larvae and scored for rate of 
eclosure as adults, we found that they are extremely sensitive to irradiation: only 
8% eclose (Figure 21). This outcome was surprisingly different from previous 
reports on irradiation survival of wildtype laboratory strains: survival rates of 
wildtype strains are significantly better than our result, nearing 60% survival on 
an average (Jaklevic et al., 2006; Jaklevic and Su, 2004; Sogame et al., 2003). 
Moreover, we found that p535A-1-4 mutants exhibited 44% irradiation survival, 
higher than the y w control (Figure 21). This was again in contrast to that 
reported before: p53 mutants make flies sensitive to irradiation (Jaklevic and Su, 
2004; Sogame et al., 2003). We speculated that these vast differences in the 
results could be due to unrecognized background mutations that have 
accumulated over time in the stock. The best way to approach this conflict was to 
diminish any genetic variability between the individuals of a single stock by 
building stocks with a genetically uniform background, or at least one closer to 
uniformity, except for the introduction of desired mutations or transgenes.  
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Background-reduced stocks, built from the original laboratory strain, 
y w, show significant variation in sensitivity to irradiation.  To investigate the 
high sensitivity of our y w, I generated several lines with reduced background 
variation, by setting up several single male to single female crosses and 
maintaining them over generations. These derivative lines were called y wBR, 
where BR stands for background reduced. I tested the y wBR lines individually for 
survival rates following exposure to irradiation. Interestingly, I found that the 
irradiation survival rates of all the tested y wBR lines improved over that of the 
original y w stock, and also vary significantly between themselves (Figure 22). Of 
these, y wBR3 line showed a median effect and so, I chose y wBR3 line for further 
experimental procedures. Males were found to be more sensitive than females to 
irradiation in all y wBR3 lines, a well-known phenomenon that can be accounted 
for by the hemizygosity of the X chromosome in males.  
Background-reduced p535A-1-4 is more sensitive to irradiation.  We 
next introgressed p535A-1-4 mutant strain into the y wBR3 background in order to 
give it a genetic background equivalent to that of y wBR3, except for the deletion of 
the p53 gene region (henceforth referred to as y wBR3; p535A-1-4). When tested for 
irradiation survival, we found that y wBR3; p535A-1-4 homozygous mutants become 
sensitive to irradiation, similar to previous reports (Figure 23). However, the rate 
of survival of y wBR3; p535A-1-4/+ heterozygotes is not significantly different from 
that of y wBR3 wildtype controls, suggesting that losing a single copy of the p53 
gene does not sensitize them to irradiation (Figure 23). Since ubiquitous p53 
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overexpression by Actin-Gal4 or heat-shock inducible Gal4 kills the organism, 
they could not be used for testing irradiation survival.  
Thus, by reducing unrecognized background effects, our results of 
irradiation survival of wildtype and p53 mutant strains become comparable with 
previously reported data. 
corp+ promotes survival of males after exposure to irradiation.  We 
next tested whether corp alters survival rates following irradiation. Since we have 
previously shown that corp is a negative regulator of p53, we thought that the 
corp mutant might produce an opposite effect to that of p53 on organismal 
viability following irradiation. Interestingly, we found that the corp95B mutant, like 
the p53 mutant, is sensitive to irradiation (Figure 24A,B). However, another corp 
mutant, corp1A, failed to reproduce the result produced by corp95B: it did not 
change survival rate, compared to wildtype (Figure 24B). This can be explained 
by the possibility that corp1A may not be a mutant at all, as verified by mapping 
for deletion of the genomic region in corp1A by PCR. My PCR results indicate that 
virtually no part of corp is missing in corp1A (Figure 24C-E). So, the corp1A 
irradiation survival result cannot be trusted with regard to accounting for how a 
corp null allele behaves. Further, it is to be noted that the two corp mutants were 
not introgressed into the y wBR3 background. So, the possible effect of 
background variability between the control and the mutants on irradiation survival 
cannot be overlooked. One way to address this problem is to construct a corp 
mutant in a y wBR3 background. This project is currently underway by others in 
the lab. 
 127 
 In order to verify the effects of corp95B on irradiation survival, I next 
wanted to see if corp+ overexpression produces an opposite effect to that 
produced by corp95B. I ubiquitously overexpressed EP-corp+ by the Actin-Gal4 
driver and tested for organismal viability following irradiation. The EP-corp+ and 
the Actin-Gal4 lines were introgressed into the y wBR3 background to maintain the 
homogeneity of the genetic background of all the lines that were being tested. I 
found that corp overexpression makes the males significantly more resistant to 
irradiation and enhances their survival rate, compared to the controls (Figure 25, 
Table 8). In females, however, it does not show any effect (Figure 25, Table 8). 
This leads to the question of why corp+ helps only the males to survive better to 
irradiation. Is there a possibility of background suppressors that are playing a role 
here affecting female survival? Or, does it unveil an unknown characteristic 
feature of corp? These questions necessitate the generation of an isogenic 
background where all the genes would have a single allele and no variation, 
unless otherwise introduced. 
Nevertheless, the disparate effects of p53 and corp+, at least in males, on 
survival rate following irradiation-induced DNA damage may be explained in a 
number of ways. p53 mutants are sensitive to irradiation because the DNA repair 
pathway is blocked in them and the DNA repair pathway genes have been 
reported to be essential for irradiation survival (Jaklevic et al., 2006; Jaklevic and 
Su, 2004). Interestingly, it has been found in mammalian cells that UV-radiation 
exposure induces P53 expression in a dose-dependent manner and a lower P53 
expression level correlates with transcription of DNA damage repair genes while 
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a higher dose of P53 is required for transcription of pro-apoptotic genes (Latonen 
et al., 2001; Li and Ho, 1998).  In this vein, it can be reasoned that corp+ 
overexpression-mediated downregulation of P53 significantly reduces its levels 
so that it cannot induce apoptosis; however, the residual level of P53 that still 
persists may be adequate to induce DNA repair. That may lead to an increased 
survival rate. Another possible explanation of the corp+- mediated increased 
organismal viability is that the corp+- mediated P53 downregulation delays 
apoptosis that gives the DNA repair machinery extra time to repair the damaged 
genome and save the cells, thus enhancing adult eclosure rate. Alternatively, it 
can also be hypothesized that corp has other targets besides p53 and that the 
role of corp in irradiation survival may be mediated through these targets, for 
example, through downregulation of inhibitors of the DNA repair pathway. 
 
Future experiments 
1. Generate an isogenic y w stock, introgress all transgenes and mutants 
tested in that background, and recheck irradiation survival data. 
2. If corp+-induced irradiation resistance result still holds true, then test if 
corp+ overexpression can still enhance organismal survival in a p53 mutant 
background: EP-corp+; UAS-GFP Actin-Gal4; p535A-1-4.  
3. Test if corp+ induces DNA repair: Irradiate EP-corp+ overexpressing 
larvae at 200 rads, dissect their wing and eye imaginal discs over a time-course 
after irradiation, and stain with H2AγX, marker of DNA damage. I would expect to 
find a decrease in H2AγX staining in corp+ overexpressing discs. Verify if a 
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decrease in staining is displayed by the corp95B mutant. Next, this experiment can 
be performed in a p53 mutant background, to check if corp+ induces DNA repair 
in a P53-independent way. 
4. To find out genes that are upregulated or downregulated by corp 
induction without and after DNA damage: Generate a RNAseq data of corp+ 
overexpressing and corp95B lines with and without irradiation treatment. I would 
expect to find many targets of corp other than p53.  
 
Materials and methods 
Drosophila stock collections.  Construction of p535A-1-4 has been 
described previously (Xie and Golic, 2004).The Bloomington stock used was 
P{EPgy2}CG1632EY03495 (BL 15650). The following lines were obtained from our 
laboratory collection: y w, y w; UAS-GFP Actin-Gal4/CyO and y w; Sb/TM6, Ubx. 
Constructing lines with lesser background variability.  11 batches of 
single male to single female crosses from the original y w laboratory stock were 
carried out to build up y w lines with lesser degree of background variability 
(referred to as y wBR1-11) and were maintained thereafter. Then, y w EP-corp+, y 
w; UAS-GFP Actin-Gal4/CyO, and y w; p535A-1-4 strains were introgressed into 
the y wBR3 reduced background strain in a manner similar to making recombinant 
inbred lines. Briefly, y w EP-corp+, y w; UAS-GFP Actin-Gal4/CyO females were 
crossed to y wBR3/Y males; from the progenies, y w EP-corp+/ y wBR3, y w/ y wBR3; 
UAS-GFP Actin-Gal4/+, and y w/ y wBR3; +/CyO virgins were collected and were 
crossed to y wBR3/Y males repeatedly for 5 generations. The undisrupted 
 130 
presence of the transgenes in successive generations was verified by the w+ eye 
color marker for EP-corp+ and the GFP fluorescence for UAS-GFP Actin-Gal4. 
The transgenic lines, introgressed into the isogenic background, were henceforth 
referred to as y wBR3 EP-corp+ and y wBR3; UAS-GFP Actin-Gal4/CyO. Since y w; 
p535A-1-4 is not phenotypically marked, it could be directly introgressed into y 
wBR3. So, y w; Sb/TM6, Ubx was first introgressed into y wBR3 line for 3 
generations in the same way as described above, and then y w; p535A-1-4 was 
further introgressed into y wBR3; Sb/TM6, Ubx for another three generations. In 
each generation, y w/y wBR3; p535A-1-4/TM6, Ubx virgins, marked by Sb+ Ubx were 
collected and then crossed to y wBR3/Y; Sb/TM6, Ubx males.  
Irradiation.  15-18 wandering third instar larvae were collected in clean 10 
mm petri plates and irradiated at 4000 rads in a TORREX120D X-ray generator 
(Astrophysics Research Corp, CA), set at 110kV and 5mA. The base of the petri 
plates was either covered with a moistened Whatmann or construction paper (to 
ensure that the larvae are not drying up quickly) or was without a cover. These 
larvae were returned to fresh food and incubated at 25°C until further 
experimental treatments. 
Calculating irradiation viability.  Irradiated larvae were returned to food 
and incubated at 25°C and allowed to eclose. All the eclosed individuals were 
counted, including the ones that got stuck to the food and died. Since the flies 
had spread-out wings as a result of irradiation exposure and could not fly well, 
getting stuck to the food was a commonly observed phenomenon. Rate of 
irradiation viability and sex ratios were calculated. 
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PCR.  Deletions of the genomic region in the corp mutants were mapped 
by PCR amplification of genomic DNA isolated from the adult flies of 
homozygous mutants. Primer sets used: FW 1: 
5’CCAAGCGAACGCATCGCTG3’, FW 2: 5’GAAGAGGTCATCTCCCAAGG3’, 
RV1: 5’CTTAGGAACAATGGTTCAACC3’ and RV2: 
5’GCAGCCGAGGTATGGAAATC3’. 
Graphical methods and statistical analyses.  Construction of graphs 
and calculations of statistical significance were performed using Prism 5.0 
(Graphpad). The contingency test was used in all cases.  
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Figure 21. p535A-1-4 null mutant survives better than original laboratory y w 
strain following irradiation. Rate of irradiation survival was measured as the 
ratio of eclosed adults to total number of irradiated larvae. The graph represents 
percentage of viability of y w laboratory strain and p535A-1-4, with (pink) and 
without (yellow) irradiation (IR). The larvae were irradiated at 4000 rads. L3, 
number of larvae irradiated. Irradiation was performed in empty petriplates 
without a moistened paper. 
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Figure 22. y wBR stocks differ in irradiation sensitivity. The graph represents 
the percent viability of five background-reduced (BR) stocks in males to females, 
with and without irradiation exposure. Color-coding for individual categories are 
shown in the inset. L3, total number of larvae irradiated; N, total number of adults 
eclosed. P values are presented for variability of viability rates between the 
irradiated y wBR stocks, only where statistically significant. Larval irradiation was 
performed in petriplates coated with a moistened Whatmann paper. 
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Figure 23. The y wBR3; p535A-1-4 null mutation sensitizes organisms to 
irradiation. Percent viability of males (black) to females (white) in ywBR3 and 
ywBR3; p535A-1-4 homozygotes and heterozygotes is presented in graph. L3, total 
number of larvae irradiated; N, total number of adults eclosed. Larval irradiation 
was performed in petriplates coated with a moistened Whatmann paper. 
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Figure 24. corp95B mutants are sensitive to irradiation. (A) Percent viability of 
corp95B with and without larval exposure to irradiation (IR), in empty petriplates 
without a moistened paper. 
 (B) In a second set of experiments, sex ratio of eclosed male to female 
progenies from four different crosses is presented in the graph. In this set, 
irradiation of larvae was performed on moistened paper coated petriplates. Two 
corp mutant lines, corp95B and corp1A, the EP-corp+ and the y wBR3 males were 
individually crossed to C(1)Dx/Y females, such that all the male progenies 
inherit the X chromosome from their dad and the female progenies receive the 
C(1)Dx chromosome from their mom, ensuring that any effect on irradiation 
viability due to the mutant or the transgenic backgrounds would remain confined 
only to the male progenies. Sex ratio from the nonirradiated control cross, 
corp95B x C(1)Dx/Y is also presented. L3, total number of larvae irradiated; N, 
total number of adults eclosed. Statistical significance calculated is presented in 
Table 8.  
(C-E) Identifying deleted genomic regions of corp mutants. Genomic regions of 
corp and its neighboring gene, CG1632, are denoted along the length of the 
DNA. Black rectangles: exons, black connecting line: intron. Arrow denotes the 
direction of transcription of the genes. corp is located within the intron of 
CG1632. Genomic deletions of 95B and 1A corp mutants are identified by PCR 
amplification of corp genomic region.  Primer pairs used: FW1, RV1, and FW2, 
RV2. Amplified products were run on the four lanes of a gel, marked 1 through 4: 
(1) y w; (2) corp1A; (3) corp95B; and (4) a third corp mutant. Both primer sets fail to 
detect any amplicon in corp95B, while presence of an amplicon, similar in size to 
that of y w wildtype control, is detected in corp1A by FW2, RV2. M1 is a 1 kb 
ladder and M2 is the 100 bp ladder. The horizontal red arrowhead points to the 
size expected in the y w control.  
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Figure 25. corp+ overexpression helps males to survive irradiation 
exposure. Percent viability of all the progeny classes from three different 
crosses (color-coded in the inset) are presented in the graph. The crosses are-    
(1) y wBR3/Y; UAS-GFP Actin-Gal4/CyO x y wBR3 (Column 1: blue), (2) y wBR3/Y; 
UAS-GFP Actin-Gal4/CyO x y wBR3 EP-corp+ (Column 2: yellow), and (3) y wBR3 
EP-corp+/Y x y wBR3; UAS-GFP Actin-Gal4/CyO (Column 3: pink), where corp+ is 
overexpressed in none of the blue progeny classes, both yellow Cy+ males and 
females and only pink Cy+ females. L3, total number of larvae irradiated from 
each cross; N, total number of adults eclosed from each cross. Data are 
represented as mean + SEM. Statistical significance calculated is presented in 
Table 8.  
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Table 8. Statistical significance of corp mutant or corp+ overexpression-
mediated variation of irradiation survival. 
 
 
A. Experiment: corp mutant irradiation survival (Figure 19) 
 
Parameter compared: Proportion of eclosed males of the total larvae 
irradiated 
 
Crosses 
 + IR - IR 
corpiA/Y x 
C(1)Dx 
EP-corp+/Y 
x C(1)Dx 
y wBR3/Y 
x C(1)Dx  
corp95B/Y x 
C(1)Dx 
 
 
+ IR 
corp95B/Y x 
C(1)Dx 
 
P<0.0001 
 
P<0.0004 
 
P<0.0001 
 
P<0.0001 
EP-corp+/Y x 
C(1)Dx 
 
P>0.05 
 
- 
 
P>0.05 
 
- 
 
B. Experiment: corp+ overexpression irradiation survival (Figure 20)  
 
1. Parameter compared: Proportion of eclosed Cy+ to Cy males  
Parameters Column 1 Column 3 
Column 2 P<0.0001 P<0.0001 
Column 3 P>0.05 - 
2. Parameter compared: Proportion of eclosed Cy+ to Cy females  
Parameters Column 1 Column 3 
Column 2 P>0.05 P>0.05 
Column 3 P>0.05 - 
3. Parameter compared: Proportion of Cy+ eclosed males of the total  
larvae irradiated 
Parameters Column 1 Column 3 
Column 2 P<0.0001 P<0.0002 
Column 3 P>0.05 - 
4. Parameter compared: Proportion of Cy+ eclosed females of the total 
larvae irradiated 
Parameters Column 1 Column 3 
Column 2 P>0.05 P>0.05 
Column 3 P>0.05 - 
 
Note. Statistical significance is calculated between two classes of crosses or 
parameters, as indicated row-wise and column-wise. 
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CHAPTER 6 
 
DEFINED GENETIC PATHWAYS TO SURVIVE 
IRREPARABLE DNA DAMAGE: MAKING 
SENSE OF IT 
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Chromosomal rearrangements may promote mutation or loss or altered 
regulation of essential genes at or near the breakpoints and duplication or 
deletion would alter the gene dosage. If any of these events hinder the 
checkpoint or apoptotic pathway components, it would heighten the probability of 
survival of cells with unrepaired damage, thus precipitating the event of 
carcinogenesis. For example, by blocking the downstream effectors in the 
apoptotic pathways, the cells survive better (Colombani et al., 2006; Kurzhals et 
al., 2011; Peters et al., 2002; Titen and Golic, 2008). Our findings suggest that 
fs(1)Yb+ plays a role in eliminating cells that have lost a telomere (Chapter 4). 
So, if fs(1)Yb is mutated, cells with a damaged genome may continue to survive, 
eventually enhancing genomic instability in the organism. On the other hand, 
there are components that directly promote suppression of cell death and 
upregulation of their levels would also increase cell survival and potentiate 
genome instability. For instance, we demonstrated that corp+ overexpression 
exhibits anti-apoptosis by downregulating P53 levels (Chapter 3). 
We have demonstrated the existence of two distinct pathways under p53 
with opposite modes of function: the hid-, reaper-mediated pro-apoptotic pathway 
and corp-mediated anti-apoptotic pathway. Thus, it is intriguing that p53 can 
induce two apparently opposing functions. Previous works have reported that the 
different isoforms of p53 differentially regulate apoptosis and apoptosis-induced 
proliferation (Dichtel-Danjoy et al., 2012). It is yet to be found out if the pro-
apoptotic (for example, hid) and anti-apoptotic (for example, corp) effectors of 
p53 are also differentially regulated by the isoforms of p53. The different 
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functional consequences of P53 may also emerge from the multiple post-
translational modifications of P53, including phosphorylation, acetylation, 
sumoylation that participate in controlling its function (Gatz and Wiesmüller, 
2006; Mauri et al., 2008). 
It is important to note that merely allowing cells to survive withstanding 
DNA damage by blocking the death inducers would not propagate a healthy 
living environment at the systemic level; it would affect the survival of the 
organism eventually through causing widespread genomic aberrations. In 
support, we found, similar to that reported previously (Jaklevic et al., 2006; 
Jaklevic and Su, 2004), that p53 mutants are more sensitive to exposure to 
irradiation (Chapter 5). Even though p53+-mediated apoptosis is blocked in these 
organisms, the load of an unstable genome, produced by blocking p53+-mediated 
DNA repair, drives them to eventually die through aneuploidy-mediated and other 
p53-independent cell-death mechanisms (McNamee and Brodsky, 2009; Titen 
and Golic, 2008; van Bergeijk et al., 2012; Wichmann et al., 2006). So, some 
mode of permanently stemming the damaged DNA is desired to survive the loss. 
This can be achieved by a third way where cells add a new telomere 
complex to the broken end, which cannot be otherwise repaired. Irreparably 
broken ends in the germline have been previously shown to be fixed by means of 
this mechanism in the male germline of Drosophila (Ahmad and Golic, 1998; 
Titen and Golic, 2010). In fact, seminal works by Barbara McClintock in the 
germline of maize showed that when a broken chromosome was delivered by the 
sperm to the egg, the breakage-fusion-bridge cycle continued in the endosperm 
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but ceased in the zygote, where it behaved as though it was healed at the broken 
end (McClintock, 1941). De novo telomere addition was also reported as a 
mechanism to rescue cells in yeast induced with dicentric-mediated chromosome 
break (Jager and Philippsen, 1989). The analogy between McClintock’s findings 
in plant with that in yeast and Drosophila is quite obvious and a parallel to these 
phenomena is observed in mammals in the context of functional telomerase 
expression in the germline, suggesting that a telomere can be reconstituted at 
the broken end (Gao et al., 2008; Shay and Wright, 2001). The intervening steps 
between generation of a broken chromosome in the germline and recovery of a 
healed chromosome in the progeny are only partially characterized. Unpublished 
work from our lab by Dr. Rebeccah Kurzhals characterized a gene, hiphop, that 
plays a distinct role in inducing de novo telomere addition, resulting in 
suppression of apoptotic phenotype in the BARTL assay and highly increasing 
the rate of broken-and-healed chromosome transmission through the germline. 
As for the existence of the chromosome healing pathway in the soma, initial 
works reported the addition of new telomeres at the end of double-strand breaks 
in mouse embryonic stem cells and terminally deleted chromosomes in human 
lymphoblastoid cells lines (Flint et al., 1994; Sprung et al., 1999). However, 
telomerase was active in both the stem cells and tumor-derived cell line, which 
played a role in reconstituting the telomeric end. Some preliminary works in 
Drosophila show the possibility of somatic existence of chromosome healing 
(Sergio Pimpinelli, personal communication). Moreover, the fact that hiphop+ 
produces wildtype-like eyes in the BARTL assay also supports the theory of 
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somatic de novo telomere addition. However, chromosome healing in the soma 
has not yet been well established or documented. Nevertheless, aberrant 
addition of de novo telomeres at broken, nontelomeric ends of chromosomes can 
also be proved deleterious by hindering DNA repair and leading to aneuploidy. 
Studies in yeast have shown that ATR mediates repression of telomerase 
function in response to DNA DSBs (Makovets and Blackburn, 2009; Zhang and 
Durocher, 2010).  
Following extensive cell death, tissue recovery can also be mediated 
through compensatory proliferation of the neighboring cells triggered by the 
apoptotic cells, so that the organism can survive without compromising 
development. The longer that dying cells persist, the greater is the signal for 
compensatory proliferation to the surrounding cells. To date, multiple groups 
have reported the phenomenon of apoptosis-induced compensatory proliferation 
(Fan and Bergmann, 2008; Huh et al., 2004; Ryoo et al., 2004; Warner et al., 
2010; Wells et al., 2006), although it is mostly the surrounding unaffected cells 
that proliferate to make up for the dead cells. Recent results demonstrated that 
dying cells signal other cells at their vicinity to become resistant to radiation-
induced cell death by activation of an anti-apoptotic microRNA (Bilak et al., 
2014). All these processes preserve tissue integrity and hence organismal 
survival. 
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Cell fate decisions: an important juncture 
At the end, our findings, together with those previously reported by others, 
point to the fact that there are defined pathways that control the cell fate 
decisions following irreparable damage, both towards living and towards dying. 
So now the question is what are the deciding factors of a cell’s ultimate destiny? 
The answer appears to lie in the tight control of a very complex gene regulatory 
network. My results can be encompassed to implicate multiple genes and levels 
of control in the regulation of recovery from tissue damage (Figure 26). Following 
telomere loss, the ATM and Chk2 activate p53 to induce apoptosis. P53 also 
induces corp that acts on it in a negative feedback loop to protect the tissue from 
the deleterious effect of excessive cell death. The fs(1)Yb+ plays a role in 
transposon silencing by ensuring the precise localization of Piwi and Armi 
proteins and piRNA generation. Telomere integrity has been found to be 
disrupted, probably through transposon desilencing in piwi pathway mutants, 
which also activates DDR genes (Chen et al., 2007; Khurana et al., 2010; 
Klattenhoff et al., 2007). Thus, it might look intriguing that being an upstream 
component, fs(1)Yb+, when overexpressed induces DDR phenotype, like piwi 
pathway mutants. This can be explained by the hypothesis that an optimum level 
of Fs(1)Yb is necessary for correct localization and function of Armi and Piwi, and 
that both an upregulation and a downregulation would disrupt the protein 
localization process and produce similar disintegrated chromosome ends to 
trigger DDR. This possibility is open to investigation. It is also yet to be found out 
where exactly does the fs(1)Yb feed into the DDR pathway. Since we found that 
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corp+ is epistatic to fs(1)Yb+, fs(1)Yb should be somewhere upstream to it, 
probably inducing a p53-dependent cell death. The apoptotic delay caused by 
corp may provide a window for allowing de novo telomere addition (for instance, 
by hiphop activation) or triggering compensatory cell proliferation pathway.  
Thus, putting in a nutshell, it is essential that all these components must 
interact properly to ensure that healthy cells are encouraged and allowed to 
proliferate, and cells with damaged genomes are eliminated. An integral part of 
recovering from tissue injury is a tight balance: the intrinsic capability to repair 
and regenerate without succumbing to massive cell death, but not totally blocking 
cells from dying and accumulating damaged genome at the same time. For 
example, downstream of P53, upregulation of hid-, reaper-mediated apoptosis 
will lead to decreased survival and upregulation of corp-mediated anti-apoptosis 
will lead to over-proliferation and may sustain cells with an unstable genome. 
Thus, fine-tuning of closely controlled pathways with opposite functional 
consequences is essential. This limits the accumulation of defective cells and 
helps maintain the tissue homeostasis.  
 
 
 
 
 
 
 
 
 
 
 
 152 
Figure 26. A model of pathways that determine cell fate following 
irreparable DNA damage. Following induction of a single telomere loss, ATM 
phosphorylates and activates, which in turn, activates P53. P53 transcriptionally 
activates genes (grim, hid, reaper, sickle) that induce apoptosis and corp that 
inhibits apoptosis, by acting on P53 in a negative feedback loop. The pro-
apoptotic and anti-apoptotic are finely balanced, and their over-activation 
(denoted by two red-arrows) can respectively lead to decreased organismal 
survival due to massive cell-death and over-proliferation of genes with an 
unrepaired genome, probably leading to oncogenic transformation. corp-
mediated inhibition and delay of apoptosis gives the cells an extended duration 
for triggering compensatory proliferation and de novo telomere addition (as 
mediated by hiphop). A second aneuploidy-driven, P53-independent JNK-
mediated pathway also triggers apoptosis. The fs(1)Yb gene plays a role in 
recruitment and proper localization of piwi pathway proteins (piwi and armi) for 
transposon silencing, that is important for maintenance of telomere integrity. It is 
yet to be found out where exactly it feeds into the DDR pathway. As our results 
indicate, it acts upstream of p53, probably inducing ATM or Chk2 or p53 itself, or 
even acting as an inducer of DNA damage by disrupting telomere integrity. 
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
14818 14 0 0 1 0 0  
14821 0 0 0 0 18 0 suppressor  
14830 8 0 5 10 0 0  
14833 4 0 0 3 0 0  
14841 8 0 0 2 0 0  
14846 8 0 1 5 0 0  
14851 5 0 1 8 0 0  
14854 - - - - - -  
14862 5 0 2 7 0 0  
14865 - - - - - -  
14866 7 - - - - -  
14995 18 0 2 0 0 0  
15002 8 0 5 1 0 0  
15004 - - - - - -  
15008 - - - - - -  
15037 - - - - - -  
15038 8 0 7 43 - -  
15044 6 0 0 5 0 0  
15049 - - - - - -  
15058 28 0 0 1 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
15060 5 0 1 1 0 0  
15065 8 1 0 0 0 0  
15083 14 0 0 0 0 0  
15087 18 0 2 3 0 0  
15299 10 0 2 0 0 0  
15300 12 0 1 7 0 0  
15305 35 0 2 3 0 0  
15318 18 0 4 0 0 0  
15324 9 0 6 2 0 0  
15347 17 0 0 7 0 0  
15349 5 0 2 10 0 0  
15361 17 0 1 8 0 0  
15368 6 0 0 0 0 0  
15386 9 0 2 8 0 0  
15388 10 0 0 0 0 0  
15389 8 0 10 12 0 0  
15392 19 0 1 2 0 0  
15393 5 0 2 0 0 0  
15394 4 0 1 0 0 0  
15395 4 0 2 14 0 0  
 160 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
15397 9 0 2 1 0 0  
15398 24 0 0 0 0 0  
15400 7 0 3 8 0 0  
15401 6 0 0 8 0 0  
15407 4 0 2 7 0 0  
15410 9 0 0 0 0 0  
15411 12 0 0 4 0 0  
15412 13 0 2 10 0 0  
15414 15 0 1 3 0 0  
15416 8 0 0 4 0 0  
15419 11 0 3 5 0 0  
15425 - - - - - -  
15431 7 0 4 6 0 0  
15432 18 0 3 5 0 0  
15434 11 0 0 3 0 0  
15436 11 0 2 4 0 0  
15438 12 0 7 4 0 0  
15439 11 1 0 0 0 0  
15444 12 0 4 1 0 0  
15445 15 0 7 3 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
15448 11 0 2 2 0 0  
15449 11 0 1 0 0 0  
15450 12 0 4 2 0 0  
15459 4 0 0 0 0 0  
15472 - - - - - -  
15490 20 - - 5 - -  
15492 11 0 5 1 0 0  
15497 11 0 1 2 0 0  
15500 14 0 4 1 0 0  
15528 7 0 0 2 0 0  
15529 7 0 2 5 0 0  
15541 12 0 10 2 0 0  
15543 15 0 0 3 0 0  
15544 8 0 12 8 0 0  
15577 19 0 2 4 0 0  
15592 10 0 2 4 0 0  
15595 8 0 4 7 0 0  
15623 16 0 7 1 0 0  
15634 14 0 0 3 0 0  
15637 8 0 11 29 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
15646 8 0 0 0 0 0  
15647 22 0 4 2 0 0  
15650 0 0 0 0 0 18 suppressor 
15653 5 0 0 6 0 0  
15662 8 0 12 18 0 0  
15669 14 0 3 3 0 0  
15673 8 0 4 2 0 0  
15675 6 0 5 0 0 0  
15677 5 0 3 0 0 0  
15679 18 0 1 8 0 0  
15681 6 0 5 7 0 0  
15688 12 0 2 5 0 0  
15689 1 0 1 3 0 0  
15690 12 0 2 5 0 0  
15701 12 0 0 2 0 0  
15702 4 0 0 10 0 0  
15703 15 0 10 12 0 0  
15704 5 0 0 5 0 0  
15705 18 0 7 6 0 0  
15713 - - - - - -  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
15715 9 0 12 16 0 0  
15724 20 0 6 2 0 0  
15725 - - - - - -  
15726 22 0 4 9 0 0  
15734 8 0 10 2 0 0  
15742 1 0 0 0 15 0 suppressor 
15744 7 0 0 4 0 0  
15748 14 0 4 2 0 0  
15755 19 0 9 3 0 0  
15765 0 0 2 6 0 0  
15769 22 0 2 4 0 0  
15778 0 18 9 2 0 0 enhancer 
15779 16 0 3 7 0 0  
15783 16 0 7 0 0 0  
15784 12 0 8 11 0 0  
15788 25 0 6 5 0 0  
15790 19 0 1 2 0 0  
15791 - - - - - -  
15795 16 0 16 1 0 0  
15806 12 0 0 1 0 0  
 164 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
15811 21 0 9 4 0 0  
15829 7 0 5 6 0 0  
15830 6 0 9 1 0 0  
15836 34 0 9 2 0 0  
15844 25 0 7 6 0 0  
15862 22 0 1 7 0 0  
15870 22 0 15 1 0 0  
15872 - - - - - -  
15876 - - - - - -  
15877 - - - - - -  
15879 15 0 2 6 0 0  
15881 2 0 1 0 0 0  
15883 35 0 7 22 0 0  
15885 19 - 4 0 0 0  
15886 8 0 0 5 0 0  
15887 12 0 3 2 0 0  
15888 31 0 6 3 0 0  
15894 0 12 1 0 0 0 Females 
also have 
small, 
rough eyes 
15896 12 0 0 3 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
15898 11 0 1 1 0 0  
15899 - - - - - -  
15901 - - - - - -  
15920 - - - - - -  
15934 11 0 0 1 0 0  
15937 18 0 0 4 0 0  
15939 7 0 5 2 0 0  
15941 12 0 17 0 0 0  
15945 5 0 6 9 0 0  
15954 9 0 5 1 0 0  
15977 11 0 4 3 0 0  
16003 7 0 0 3 0 0  
16008 11 0 6 3 0 0  
16363 8 0 2 5 0 0  
16373 12 0 10 11 0 0  
16374 5 0 7 7 0 0  
16381 8 0 3 1 0 0  
16383 14 0 8 2 0 0  
16384 7 0 0 1 0 0  
16385 7 0 8 3 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
16388 34 0 5 4 0 0  
16393 0 0 15 0 0 0 Females 
also have 
small eyes 
16394 28 0 16 4 0 0  
16400 10 0 0 0 0 0  
16404 5 0 0 0 0 0  
16443 - - - - - -  
16537 12 0 8 10 0 0  
16538 7 0 0 2 0 0  
16617 5 29 18 0 0 0 enhancer 
16626 8 0 2 2 0 0  
16633 8 0 2 1 0 0  
16635 6 0 9 0 0 0  
16640 7 0 0 0 0 0  
16642 - - - - - -  
16645 8 0 2 4 0 0  
16648 11 0 0 5 0 0  
16650 12 0 0 4 0 0  
16660 10 0 7 2 0 0  
16670 14 0 1 0 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
16684 9 0 0 2 0 0  
16685 9 0 1 2 0 0  
16686 24 0 5 1 0 0  
16691 9 0 0 1 0 0  
16693 20 0 6 0 0 0  
16708 9 0 0 4 0 0  
16719 4 0 4 38 0 0  
16726 10 0 0 0 0 0  
16733 9 0 0 0 0 0  
16734 15 0 3 8 0 0  
16739 21 1 4 0 0 0  
16752 9 0 1 4 0 0  
16763 0 0 0 0 0 0 15 Cy+ 
males, 8 
Cy+ and 9 
Cy females  
16771 9 0 0 0 0 0  
16772 8 0 1 2 0 0  
16779 12 0 0 4 0 0  
16781 15 0 0 6 0 0  
16782 21 0 6 3 0 0  
16785 10 1 0 0 0 0  
 168 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
16786 3 0 1 2 0 3  
16789 3 0 1 0 0 0  
16796 15 0 5 2 0 0  
16803 14 0 5 1 0 0  
16809 7 0 1 2 0 0  
16811 16 0 3 0 0 0  
16813 6 0 0 0 0 0  
16817 22 0 3 2 0 0  
16824 14 0 1 2 0 0  
16827 11 0 5 1 0 0  
16835 7 0 0 0 0 0  
16836 18 0 3 2 0 0  
16858 0 18 0 0 0 0 No Cy+ 
females 
16859 16 0 1 0 0 0  
16862 16 0 6 1 0 0  
16866 10 0 2 2 0 0  
16877 7 0 22 0 0 0  
16884 11 0 4 1 0 0  
16889 12 0 3 2 0 0  
16891 5 0 0 4 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
16892 14 0 5 1 0 0  
16897 15 0 0 4 0 0  
16907 10 0 6 2 0 0  
16912 11 0 3 1 0 0  
16913 14 0 2 1 0 0  
16915 12 0 2 0 0 0  
16918 9 0 3 4 0 0  
16923 16 0 2 4 0 0  
16926 5 0 3 7 0 0  
16939 18 0 3 2 0 0  
16940 3 0 0 1 0 0  
16945 6 0 0 0 19 0 suppressor 
16946 8 0 2 6 0 0  
16955 10 0 2 2 0 0  
16959 15 0 1 0 0 0  
16963 9 0 5 2 0 0  
16965 7 0 0 1 0 0  
16976 17 0 4 0 0 0  
16977 5 0 1 0 0 0  
17303 9 0 0 5 0 0  
 170 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
17319 8 0 0 0 0 0  
17330 10 0 2 4 0 0  
17331 14 0 6 1 0 0  
17338 19 0 8 1 0 0  
17343 10 0 1 2 0 0  
17347 2 0 0 3 0 0  
17348 12 0 2 0 0 0  
17353 17 0 4 0 0 0  
17354 - - - - - -  
17355 14 0 3 0 0 0  
17357 12 0 9 0 71 0 suppressor
? 
17358 18 0 9 6 0 0  
17361 23 0 16 14 0 0  
17363 - - - - - -  
17373 11 0 5 8 0 0  
17376 9 0 7 4 0 0  
17377 15 0 11 7 0 0  
17378 16 0 11 12 0 0  
17380 0 - 0 0 0 0 ?? 
17381 6 0 18 2 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
17386 14 0 12 0 0 0  
17395 19 0 15 0 0 0  
17397 15 0 17 14 0 0  
17403 8 0 2 5 0 0  
17411 7 0 11 9 0 0  
17416 19 0 5 1 0 0  
17420 16 0 18 21 0 0  
17439 7 0 8 9 0 0  
17440 12 0 10 9 0 0  
17443 4 0 7 9 0 0  
17445 19 0 14 9 0 0  
17447 10 0 8 2 0 0  
17453 22 0 3 2 0 0  
17455 19 0 13 8 0 0  
17458 19 0 9 11 0 0  
17477 17 0 16 20 0 0  
17478 12 0 7 9 0 0  
17482 11 0 8 9 0 0  
17491 27 0 22 0 0 0  
17494 16 0 5 2 0 0  
 172 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
17496 5 0 3 32 0 0 suppressor
? 
17497 15 0 4 0 0 0  
17507 16 0 0 24 0 0  
17509 14 0 14 3 0 0  
17512 8 0 1 0 6 0  
17529 17 0 4 0 0 40 suppressor
? 
17535 10  0 12 5 0 0  
17541 12 0 9 6 0 0  
17544 17 0 4 7 0 0  
17545 - - - - - -  
17549 11 0 10 2 0 0  
17557 8 0 3 6 0 0  
17560 10  0 5 0 0 0  
17563 51 0 1 8 0 0  
17565 10 0 0 2 0 0  
17566 8 0 5 2 0 0  
17571 11 0 3 0 0 0  
17585 12 0 0 3 0 0  
17590 15 0 11 0 33 0 suppressor
? 
17592 22 0 0 15 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
17596 11 0 7 9 0 0  
17598 2 0 4 2 0 0  
17602 8 0 0 6 0 0  
17604 21 0 18 12 0 0  
17606 12 0 0 8 0 0  
17608 - - - - - -  
17609 18 0 9 11 0 0  
17613 19 0 8 9 0 0  
17616 - - - - - -  
17631 12 0 11 9 0 0  
17648 4 0 12 0 0 0  
17674 0 0 0 0 0 104 suppressor 
19646 22 0 14 12 0 0  
19666 16 0 0 0 0 0  
19685 19 0 11 14 0 0  
19689 24 0 0 0 0 0  
19697 18 0 0 0 0 0  
19717 19 0 6 2 0 0  
19730 8 0 11 4 0 0  
19731 12 0 4 1 0 0  
 174 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
19732 22 0 0 0 0 0  
19733 21 0 18 11 0 0  
19744 11 0 7 2 0 0  
19773 31 0 12 11 0 0  
19779 25 0 0 0 0 0  
19797 17 0 3 8 0 0  
19802 3 0 4 1 0 0  
19817 8 0 5 1 0 0  
19822 22 0 11 9 0 0  
19823 15 0 8 2 0 0  
19833 11 0 4 0 0 0  
19839 18 0 8 6 0 0  
19866 13 0 7 2 0 0  
19892 16 0 8 2 0 0  
19898 2 0 1 9 0 0  
19900 14 0 11 5 0 0  
19902 6 0 4 0 0 0  
19934 15 0 8 2 0 0  
19942 16 0 1 0 27 0 suppressor
? 
19943 11 0 5 2 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
19947 17 0 12 9 0 0  
19949 5 0 7 2 0 0  
19950 12 0 8 9 0 0  
19954 - - - - - -  
19957 17 0 8 7 0 0  
19963 24 0 0 0 0 0  
19964 19 0 13 11 0 0  
19969 7 0 9 2 0 0  
19976 8 0 12 6 0 0  
19990 15 0 11 8 0 0  
20005 12 0 7 5 0 0  
20006 0 0 8 0 0 0 inducer? 
20010 32 0 0 14 0 0  
20011 19 0 0 0 0 0  
20024 23 0 17 14 0 0  
20044 15 0 8 0 12 0  
20065 0 0 0 2 0 0  
20069 7 0 9 3 0 0  
20074 12 0 9 6 0 0  
20077 7 0 1 4 0 0  
 176 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
20101 5 0 1 1 0 0  
20116 3 0 1 1 0 0  
20118 14 0 12 10 0 0  
20126 13 0 0 9 0 0  
20144 19 0 14 12 0 0  
20177 9 0 0 2 0 0  
20194 21 0 16 0 0 0  
20197 12 0 4 7 0 0  
20216 7 0 1 4 0 0  
20217 17 0 0 12 0 0  
20218 24 0 21 0 0 0  
20256 22 0 0 21 0 0  
20257 18 0 11 14 0 0  
20258 9 0 5 0 58 0 suppressor
? 
20269 18 0 8 3 0 0  
20294 13 0 11 9 0 0  
20295 9 0 4 3 0 0  
20297 12 0 0 14 0 0  
20299 17 0 `5 0 0 0  
20317 6 0 0 1 0 0  
 177 
Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
20318 19 0 0 23 0 0  
20320 6 0 12 9 0 0  
20325 13 0 0 11 0 0  
20337 8 0 0 9 0 0  
20340 18 0 12 14 0 0  
20348 8 0 7 0 0 0  
20628 6 0 0 0 17 0  
20635 7 0 0 0 0 0  
20642 - - - - - -  
20654 19 0 14 08 0 0  
20666 17 0 0 0 0 0  
20667 9 0 4 3 0 0  
20668 16 0 0 7 0 0  
20674 5 0 2 0 0 0  
20682 12 0 8 0 0 0  
20687 8 0 6 8 0 0  
20693 12 0 9 0 0 0  
20697 9 0 0 0 0 0  
20705 19 0 6 9 0 0  
20717 12 0 0 14 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
20718 11 0 3 1 0 0  
20720 12 0 5 9 0 0  
20721 12 0 5 0 0 0  
20723 12 0 11 8 0 0  
20733 15 0 9 8 0 0  
20742 8 0 0 9 0 0  
20745 21 0 0 9 0 0  
20786 17 0 16 4 0 0  
20792 9 0 2 5 0 0  
20793 24 0 0 0 0 0  
20798 23 0 3 2 0 0  
20807 14 0 4 8 0 0  
20816 17 0 0 8 0 0  
20817 17 0 10 0 0 0  
20827 3 0 3 0 0 0  
20833 3 0 2 0 0 0  
20847 14 0 6 5 0 0  
20849 8 0 0 1 0 0  
20856 - - - - - -  
20857 12 0 9 6 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
20858 14 0 5 8 0 0  
20861 - - - - - -  
20881 6 0 0 4 0 0  
20884 4 0 0 0 0 0  
20885 14 0 4 38 0 0  
20917 8 0 9 14 0 0  
20923 12 0 3 0 0 0  
20924 12 0 0 9 0 0  
20936 11 0 0 7 0 0  
20940 21 0 0 18 0 0  
20944 15 0 0 9 0 0  
20948 6 0 0 2 0 0  
20951 10 0 0 8 0 0  
20952 9 0 0 5 0 0  
20961 12 0 0 14 0 0  
20963 9 0 1 0 0 0  
20964 14 0 6 2 0 0  
21081 17 0 0 12 0 0  
21084 3 0 4 2 0 0  
21097 10 0 0 0 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
21098 18 0 14 0 0 0  
21100 6 0 3 2 0 0  
21102 11 0 3 1 0 0  
21103 15 0 0 5 0 0  
21105 0 - 0 0 0 0 No Cy 
males too 
21111 - - - - - -  
21112 21 0 17 12 0 0  
21113 14 0 8 9 0 0  
21131 15 0 0 5 0 0  
21133 17 0 5 3 0 0  
21142 0 0 0 1 0 0  
21146 11 0 0 0 0 0  
21151 4 0 0 5 0 0  
21153 12 0 6 5 0 0  
21169 6 0 11 0 0 0  
21170 2 0 14 1 0 0  
21184 12 0 5 8 0 0  
21189 9 0 5 8 0 0  
21192 0 12 8 2 0 0  
21198 8 0 7 9 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
21199 - - - - - -  
21202 12 0 7 0 0 0  
21210 8 0 2 5 0 0  
21211 14 0 7 0 0 0  
21222 15 0 12 0 0 0  
21230 8 0 4 5 0 0  
21233 12 0 9 0 0 0  
21235 18 0 0 0 0 0  
21353 23 0 19 3 0 0  
21368 24 0 19 0 0 0  
21375 18 0 6 0 0 0  
21377 16 0 1 0 0 0  
21380 11 0 0 0 0 0  
21387 12 0 9 0 0 0  
21388 11 0 8 0 0 0  
21404 11 0 1 0 0 0  
21419 9 0 0 4 0 0  
21420 10 0 5 4 0 0  
21423 12 0 7 16 0 0  
21424 18 0 11 9 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
21426 15 0 8 6 0 0  
21427 7 0 0 0 0 0  
21428 8 0 9 7 0 0  
21429 - - - - - -  
21430 9 0 0 8 0 0  
21436 11 0 8 0 0 0  
21438 12 0 0 0 0 0  
21451 17 0 12 13 0 0  
21955 11 0 5 0 0 0  
22137 12 0 5 0 0 0  
22151 3 0 7 12 0 0  
22288 22 0 12 9 0 0  
22292 9 0 6 2 0 0  
22294 14 0 0 6 0 0  
22295 - - - - - -  
22321 12 0 6 0 0 0  
22324 17 0 0 17 0 0  
22326 3 0 1 0 0 0  
22337 12 0 9 7 0 0  
22338 9 0 7 5 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
22339 4 0 11 3 0 0  
22351 3 0 0 5 0 0  
22353 8 0 1 2 0 0  
22354 11 0 0 3 0 0  
22355 20 0 2 1 0 0  
22356 10 0 1 9 0 0  
22365 14 0 10 1 0 0  
22371 12 0 0 2 0 0  
22372 4 0 2 1 0 0  
22402 7 0 5 8 0 0  
22403 6 0 0 1 0 0  
22410 0 5 2 0 0 0 72 Cy males, 
24 Cy+ 
females 
(smaller 
rough eyes): 
Gene seems 
to effect eye 
and bristle.  
22412 11 0 4 2 0 0  
22432 11 0 2 8 0 0  
22433 9 0 3 3 0 0  
22434 - - - - - -  
22439 1 0 0 5 0 0  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
22450 11 0 5 4 0 0  
22457 5 0 6 4 0 0  
22458 24 0 5 6 0 0  
22463 6 0 8 3 0 0  
22465 10 0 0 0 0 0  
22483 6 0 1 2 0 0  
22488 5 0 5 2 0 0  
22490 - - - - - -  
22492 14 0 4 0 0 0  
22494 16 0 3 0 0 0  
22519 14 0 8 10 0 0  
22524 9 0 0 1 0 0  
22534 - - - - - -  
22536 8 0 0 4 0 0  
22549 - - - - - -  
22552 - - - - - -  
22571 19 0 2 1 0 0  
22572 6 0 6 3 0 0  
22573 9 0 0 1 0 0  
22576 1 0 8 0 0 0 inducer? 
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
22593 9 0 2 2 0 0  
22594 10 0 9 7 0 0  
22596 22 0 9 2 0 0  
22627 - - - - - -  
22634 9 0 0 6 0 0  
22637 16 0 5 4 0 0  
22643 11 0 0 1 0 0  
22645 4 0 4 1 0 0  
22646 6 0 0 1 0 0  
22647 6 0 4 2 0 0  
22660 4 0 1 3 0 0  
23105 15 0 0 0 0 0  
23109 10 0 1 1 0 0  
23119 15 0 1 1 0 0  
24091 7 0 2 1 0 0  
24093 10 0 0 1 0 0  
24095 10 0 4 0 0 0  
24458 0 0 8 28 0 0 suppressor
? 
24795 15 0 0 0 0 0  
17506 - - - - - -  
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Stock Cy+ male eye phenotype Notes  
BS 1 2 3 4 5 
21079 5 0 2 2 0 0  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
APPENDIX B 
 
CONSTRUCTED STOCKS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 188 
y w/H1; P{Gal4-ey.H}4.8 P{UAS-FLP1.D}JD1 or eGUF4.8JD1/SM1, Cy 
y w/Y; P{Gal4-ey.H}4.8 P{UAS-FLP1.D}JD1 or eGUF4.8JD1/SM1, Cy 
y w/H1; P{Gal4-ey.H}4.8 {UAS-FLP}2B or eGUF4.82B/SM1, Cy 
y w EP-corp+; Sco/s2CyO  
y w EP-corp+; Sb/TM6, Ubx 
y w EP-corp+; 70FLP10/s2CyO 
y w EP-corp+; EP-Chk2+/s2CyO 
y w EP-corp+; {UAS-p53}2/s2CyO 
y w EP-corp+; {GMR-Gal4}/s2CyO 
y w EP-corp+; p535A-1-4/TM6, Ubx 
y w; UAS-corpA1 
y w; Sp/SM1, Cy; UAS-corpA1/TM3, Sb 
corp95B; Sco/s2CyO 
corp95B; UAS-corpA1/TM6, Ubx 
corp95B; nanos-Gal4 UAS-FLP95/TM6, Ubx  
EP-fs(1)Yb+; Sco/s2CyO 
EP-fs(1)Yb+; 70FLP10/s2CyO 
EP 15778; HRH00A1/s2CyO 
EP 16617; Sb/TM6, Ubx 
y w UAS-hid; Sco/s2CyO 
y w; UAS-rpr/SM1, Cy; p535A-1-4/TM6B, Tb 
y w; GMR-Gal4/SM1, Cy; p535A-1-4/TM6B, Tb 
y wBR3 
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y wBR8 
y wBR9 
y wBR3, EP-corp+ 
y wBR3; Actin5C-Gal4 UAS-GFP/SM1, Cy 
y wBR3; p535A-1-4 
 
